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Abstract
This thesis focuses on the protein kinase N family of serine/threonine protein kinases. 
This comprises three isoforms, with kinase domains highly related to the protein kinase 
C family, but with distinctive Rho/Rac dependent regulation. The critical roles played 
by Rho/Rac in regulating the cytoskeleton and cell migration/invasion led to an 
investigation into the role of PKNs in this process.
Initial work in the thesis derived from the observation that PKN 1 translocated to an 
insoluble cytosolic compartment in response to hyperosmotic stress. This had been 
shown to be dependent upon R ad  and 3-phosphoinositide dependent kinase (PDKl). 
The thesis describes the characterisation of the domain in PKN 1 responsible for the Rac- 
dependent hyperosmotic response. Through the use of PKNl/PKCzeta chimeras a 49 
amino acid sequence within the kinase domain was shown to be necessary and sufficient 
for the observed osmotic behaviour.
In developing a cell model for migration/invasion, a breast cancer cell model was 
identified that displayed high PKN expression. siRNA mediated depletion o f PKN 
iso forms or inhibition o f kinase activity, revealed a requirement for PKN in both 
migration and invasion. Comparison with other transformed cells indicated that the 
relative contribution each isoform makes towards these processes appears to be cell type 
dependent.
As a candidate downstream target, PLD has been implicated in migration and invasion 
of breast cancer cells and so the previously described interaction between PKN and 
phospholipaseD in migrating breast cancer cells was investigated. Results suggest that 
the activity of PLD contributes to the migration of MDAMB-468 cells and that the 
production of phosphatidic acid in migrating cells is stimulated by PKN.
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Chapter 1 
Signal transduction
1 Introduction
All cells must regulate their behaviour in response to cues from their environment. This 
conversion o f a specific signal or stimulus into a relevant response is termed signal 
transduction and is essential for the correct functioning and survival of both single­
celled and multicellular organisms. Receptors detect these signals and as a result o f their 
activation the activity and/or localisation of multiple intracellular mediators are affected. 
These linked series of events are termed signalling pathways and the interplay between 
different pathways generates complex signalling networks that ultimately result in an 
appropriate biological response to the signal. Since it is these signalling networks that 
control the functioning o f all tissues and organs of a multicellular organism it is not 
surprising that defects in cell signalling often results in disease. The elucidation of these 
signalling pathways is therefore critical to allow therapeutics to be developed to treat 
such diseases. Some of the general aspects of signal transduction (illustrated in Figure 
1:1) will be described here with particular emphasis on areas relevant to this thesis.
13
Figure 1:1 A generic signai transduction pathway (Downward, 2001).
Schematic illustrating some o f the important concepts o f signal transduction. The grey 
boxes indicate general components o f signalling pathways, the white boxes show 
specific examples.
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1.1 Receptors
The signals that are received by cells arrive in the form of ligands that bind to specific 
receptors. The binding of a ligand to its receptor results in changes to the conformation 
of the receptor that result in transduction and amplification o f the signal. The majority of 
ligands are too large and/or too polar to be able to pass through the membrane lipid 
bilayer and so cell surface receptors provide the means for the signal to be transduced 
across the membrane. Other ligands, such as the steroid hormones, are able to pass 
through the membrane and bind to intracellular receptors that then frequently enter the 
nucleus and bind to DNA to bring about changes in gene expression (see (Tata, 2002) 
for review). Receptors that mediate cell-cell and cell-matrix adhesion are of particular 
interest to this thesis and are discussed in more detail below.
1.1.1 Cadherins
The cadherins are a group of Ca’  ^dependent transmembrane receptors that usually 
mediate homotypic cell-cell adhesion by acting as both ligand and receptor to form cell 
contacts. There are many classes of cadherins and they are named according to the tissue 
type that they are associated with e.g. E-cadherin is primarily found in cells of epithelial 
origin. Their ability to mediate adhesion between cells that are expressing the same 
subelass of cadherin means that they play a vital role in tissue organisation in 
development and maintaining the integrity of multicellular organs (for review see 
(Ivanov et al., 2001)). At points of cell contact cadherins are dynamically linked to the 
cytoskeleton and intracellular signalling events through proteins such as the catenins 
binding to their cytoplasmic tails (Mege et al., 2006). The regulation of cell contacts is 
the subject of much investigation not least because loss of cell-cell contacts and the 
ability of cells to migrate as single cells rather than in a collective fashion is a hallmark 
o f the epithelial-mesenchymal transition (EMT, (Boyer et al., 2000) for review). This 
process has been associated with tumour progression and interestingly loss of E- 
cadherin expression or regulation has been reported in many aggressive tumours (Foty 
and Steinberg, 2004).
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1.1.2 Integrins
Integrins are a large family of heterodimeric receptors that consist o f an a  and a (3 
subunit. Both subunits contain a large extracellular domain, a membrane spanning 
region and a smaller intracellular domain. The extracellular domains associate 
noncovalently to form a functional receptor. There are currently 18 known a  subunits 
and 8 (3 subunits and these combine in various combinations to give 24 integrin 
heterodimers (for recent review see (Humphries et al., 2006)). The integrins have 
overlapping ligand binding specificities and many integrins can bind multiple 
extracellular ligands. The classical integrin binding motif found in ligands such as 
fibronectin and vitronectin is the arginine-glycine-aspartic acid (RGD) sequence. 
However most integrins do not recognise this sequence and indeed many integrins that 
bind fibronectin do so through other sites. Frequently though the recognition sites are 
short linear sequences containing an acidic residue (Ivaska and Heino, 2000). Table 1 
summarises the main ligand(s) for each integrin.
Multiple proteins are able to bind to the cytoplasmic tails of integrins and this creates 
focal adhesion sites. Binding of scaffolding proteins such as paxillin, a-actinin and 
vincuiin provide a link between the extracellular matrix and the cytoskeleton. Integrins 
lack intrinsic catalytic activity and so recruitment of proteins such as GTPases, kinases 
and phosphatases to these foeal adhesion sites provide a link between the ECM, 
cytoskeleton and intracellular signalling. This enables integrins to control aspects of cell 
behaviour such as migration, invasion, proliferation and survival (reviewed by (Geiger 
et al., 2001)). The importance of the dynamic regulation of these focal adhesion sites for 
cell migration will be discussed later.
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INTEGRIN LIGANDS
a i p i LN,CO
a2[31 LN, CO, Ihrombospondin, E-cadhcrin, tcnascin
a3pi LN, CO, thrombospondin, uPAR
a4pi Thrombospondin, MAdCAM-1, VCAM-1, FN, osleopontin, ADAM, ICAM-4.
a5pi FN, osleopontin, fibrillin, thrombospondin, ADAM, COMP, L1
a6pi LN, thrombospondin, ADAM, Cyr61
a?p i LN
aSpi Tcnascin, FN, osleopontin, VN, LAP-TGF-P, nephronectin
a9pi Tcnascin, VCAM-1, osleopontin, uPAR,plasmin, angiostatin, ADAM, VEGF- 
C,VEGF-D
alOpi LN, CO
a l i p i LN
aV pi LAP-TGF-P, FN, osleopontin, El, VN
aLp2 ICAM, ICAM-4
aMp2 ICAM, iC3b, factor X, fibrinogen, ICAM-4, heparin
aXp2 ICAM, iC3b, fibrinogen, ICAM-4, heparin, CO
aOp2 ICAM, VCAM-1, fibrinogen, FN, VN, Cyr61, plasminogen
allbp3 Fibrinogen, thrombospondin, FN, VN, vWF, Cyr61, ICAM-4, LI, CD40 ligand
aVp3 Fibrinogen, VN, vWF, thrombospondin, fibrillin, tcnascin, PECAM-1, FN, 
osleopontin.
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BSP, MFG-E8, ADAM-15, COMP, Cyr61, ICAM-4, MMP, FGF-2, uPA, uPAR, LI, 
angiostalin, plasmin, cardiotoxin, LAP-TGF-P, Dcl-1
a6p4 LN
aVp5 Osteopontin, BSP, VN, CCN3, LAP-TGF-p
aVp6 LAP-TGF-P, FN, osteopontin, ADAM
a4p? MAdCAM-1, VCAM-1, FN, osteopontin
aEp? E-cadherin
aVpg LAP-TGF-p, FN, VN
Table 1 Known ligands for the 24 identified integrin dimers.
Reviewed in (Takada et al., 2007) (Ivaska and Heino, 2000).
Abbreviations: FN, fibronectin; LN, laminin; CO, collagen; VN, vitronectin; ICAM, 
intercellular adhesion molecule; VCAM, vascular cell adhesion molecule; iC3b, 
inactivated C3b; MadCAM-1, mucosal addressin cell adhesion molecule-1; ADAM, a 
disintegrin and metalloprotease; BSP, bone sialic protein; CCN3, an extracellular matrix 
protein; COMP, cartilage oligomeric matrix protein; Cyr61, cysteine rich protein 61; LI, 
CD171; LAP-TGF-(3, TGF-(3 latency-associated peptide; PECAM-1, platelet and 
endothelial cell adhesion molecule 1 ; uPA, urokinase; uPAR, urokinase receptor;
VEGF, vascular endothelial growth factor; vWF, von Willebrand Factor.
1.2 Second messengers
Second messengers are molecules that relay and amplify the signals received by 
receptors to generate rapid and diverse responses. The activation of a single receptor 
will often result in the generation of multiple second messenger moleeules and hence the 
signal is amplified (Eyster, 1998). These second messengers are frequently able to 
diffuse to other loeations within a eell and so influence signalling distal to the location 
of the receptor. In addition second messengers can affect multiple proteins in the eell 
and therefore multiple signalling pathways can be activated in response to a single 
signal allowing integration and fine-tuning of responses. Prevalent seeond messengers 
include cyclic AMP (cAMP) (Lynch et al., 2006), diacyclglycerol (DAG) (Carrasco and 
Merida, 2007), calcium (Ca^ ) and inositol 1,4,5-triphosphate (IP3) (Brini and Carafoli, 
2000). The effect o f receptor activation and second messenger generation is to affeet the 
activity and interaction of proteins to generate signalling eascades. The meehanisms by 
which these changes are brought about are discussed below.
1.3 Post-translational modifications
Many polypeptide chains are chemically modified after they are translated to alter the 
function of the resulting protein. These modifications can involve the addition of 
biochemical groups, addition of polypeptides, altering the chemical nature of amino 
acids or structural changes to the protein (Zhu et al., 2003). Together these 
modifications add to the diversity o f functions that a protein can have. They also enable 
greater control over the response to a particular signal to be achieved by regulating the 
location and activity of the proteins within a signalling pathway. Although there are over 
200 post-translational modifications (PTMs) one of the most important and studied is 
that of protein phosphorylation.
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1.3.1 Protein Phosphorylation
Protein phosphorylation is the addition of a phosphate group to specific residues of a 
protein. The transfer of the y-phosphate group from ATP onto the hydoxyl group of 
specific residues within a protein, most commonly a serine, threonine or tyrosine 
residue, is catalysed by protein kinases. The addition of a single phosphate can 
dramatically change the activity of a protein although many proteins are phosphorylated 
on multiple residues. The beauty of phosphorylation as a molecular “on/off’ switch for 
signalling pathways arises due to the opposing actions of kinases and phosphatases, (that 
catalyse the removal o f phosphates from proteins), allowing exquisite control of the 
activity and interactions of their target proteins. The completion of the human genome 
project has revealed that there are more than 500 kinases and over 100 phosphatases 
illustrating their importance in controlling cellular activity (Mann et al., 2002).
Kinases can be grouped into three main classes based on the residues they 
phosphorylate, the serine/threonine (Ser/Thr) kinases, tyrosine (Tyr) kinases and the 
dual specificity kinases. They have been further divided into families based on sequence 
comparisons of their catalytic domains, sequence and domain structure outside of the 
catalytic domain and biological function (Manning et al., 2002).
All the classical kinases have a common bilobal catalytic domain of approximately 250 
amino acids. The small N-terminal region consists mainly of ^-sheets and the larger C- 
terminal lobe contains primarily a-helices. ATP binds in a cleft between the two lobes 
that the substrate then binds along (Hanks and Hunter, 1995). Conserved residues in the 
kinase domain then catalyse the transfer of the y-phosphate to the appropriate residue of 
the substrate. Three motifs within the catalytic domain of a kinase are thought to be 
critical for activity (Table 2); 48 proteins have been identified so far that lack one or 
more of these motifs and these pseudokinases are thought to be catalytieally inactive 
(Boudeau et al., 2006).
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Motif Function
VAIK (Val-Ala-lle-Lys) Lysine residue interacts with a  and p phosphates of ATP to 
anchor and orientate the ATP.
HRD (His-Arg-Asp) Aspartic acid residue functions as a base receptor to 
achieve proton transfer.
DFG (Asp-Phe-Gly) Aspartic acid residue binds the Mg^^ ions that coordinate 
the p and y phosphates of ATP in the binding cleft.
Table 2 Critical kinase domain motifs.
It is estimated that at any time a third of cellular proteins are phosphorylated with a 
phosphoamino acid content ratio (pSer:pThr;pTyr) of 1800:200:1 (Mann et ah, 2002). 
Phosphorylation can affect proteins in several ways to result in regulation of signal 
transduction pathways. The addition of a bulky negatively charged phosphate group 
commonly alters the conformation and hence the activity of a protein. For example 
members of the Protein kinase C (PKC) family are activated by phosphorylation on their 
activation loop residue (see section 1.8) (Parker and Parkinson, 2001), the Tyr kinase 
Src is regulated both positively and negatively by phosphorylation o f multiple residues 
(Roskoski, 2005). Altering the activity of a single enzyme such as a kinase can have 
pronounced effects on signalling by affecting the phosphorylation of multiple 
downstream targets of that enzyme producing a signalling “cascade”. In addition to 
affecting activity, phosphorylation can also control the localisation o f proteins. For 
example the Forkhead boxO (FoxO) transcription factors when phosphorylated by PKB 
are sequestered to the cytoplasm where they are unable to regulate gene expression 
(Kops and Burgering, 1999). Phosphorylation can also creating docking sites for protein 
binding domains on other cellular proteins and hence promote protein-protein 
interactions to regulate the propagation of a signal, this is discussed in section 1.5.
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The balance of phosphorylation is achieved through the kinase opposing action of 
phosphatases. Like the kinases there are three classes o f phosphatases, Ser/Thr 
phosphatases, Tyr phosphatases and dual specificity phosphatases. The Ser/Thr 
phosphatases are vastly outnumbered by the Ser/Thr kinases. Therefore to achieve 
specificity and regulation of Ser/Thr residue dephosphorylation multiple regulatory 
subunits combine with core catalytic subunits to create distinct holoenzymes with a wide 
variety of substrate specificities and subcellular localisations (Barford et al., 1998). The 
tyrosine phosphatases however do not associate with regulatory subunits but achieve 
specificity of function through the presence o f multiple regulatory and interaction 
domains (Alonso et al., 2004).
To achieve the correct response to a specific signal kinases and phosphatases must 
distinguish which residues to phosphorylate and dephosphorylate respectively from 
amongst thousands of possibilities within the cell. This specificity of action is achieved 
through multiple mechanisms such as structure of the catalytic site, local interactions 
with the substrate and the binding of scaffolding and adaptor proteins ((Ubersax and 
Ferrell, 2007) for review). The localisation of kinases and the interactions with protein 
and lipid partners to generate signalling complexes is particularly relevant to the work in 
this thesis.
1.4 Phospholipids
Phospholipids are the main constituent of membrane bilayers and as such are vitally 
important in insulating cells from the external environment and creating cellular 
compartments with different characteristics to the cytoplasm. However they also play an 
important role in signalling both by targeting proteins to specific cellular compartments 
and generating second messengers (recently reviewed (Eyster, 2007)).
The phospholipids consist primarily of the glycerophospholipids. These all have two 
fatty acid chains attached to the first and second carbons o f a glycerol molecule and a
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phosphate group attached to the third carbon (this is the parent compound, phosphatidic 
acid). The identity of the head group that is attached to this phosphate subdivides the 
glycerophospholipids into phosphatidylethanolamine, phosphatidylcholine, 
phosphatidylserine, phosphatidylglycerol and phosphatidylinositol (see Figure 1:2). The 
fatty acids in each type of glycerophospholipid and the nature of the fatty acid linkage 
can vary and so give rise to a number o f molecular species. The composition of species 
found varies between organisms and between and within cells of the same organism. 
The phosphoinositides (Pis) are particularly important in signalling and their role will 
now be considered in more detail.
Basic phospholipid structure
()
9 .
R - (  - ( ) - (  II O
H C - 0 - P - 0 \
(V
Formula of X Name of phospholipid
CHzCHzNHs^
CH2CH2N(CH3)3+
CH2CH(0H)CH20H
Phosphatidylethanolamine
Phosphatidylcholine
Phosphatidylglycerol
Phosphatidylinositol
Figure 1:2 Illustration of the different types of phospholipid.
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1.4.1 Phosphoinositides
The differential phosphorylation of the inositol ring at positions 3, 4 or 5 generates 
seven different phosphatidyl inositol (Ptdlns) lipids in higher eukaryotes. As well as 
giving rise to a number of second messengers, such as 1P3, DAG and PtdOH, the Pis 
also serve to recruit proteins containing lipid interaction domains to specific membrane 
compartments or areas of a membrane (Krauss and Haucke, 2007). Specific PI kinases 
and phosphatases act to interconvert the phosphoinositides (Pis) and hence regulate their 
function. The kinases are named after the position on the inositol ring that they 
phosphorylate i.e. PI3, PI4 and PI5 kinases. The PI3-kinase signalling pathway is the 
best understood and has been implicated in a huge range of cellular processes such as 
cell growth, proliferation, survival and cytoskeletal changes (for review see 
(Vanhaesebroeck et al., 2001)).
Eight mammalian PI3-kinases have been identified and they are grouped into three 
classes of PI3 kinases based on structural homology, regulation and substrate specificity 
(Anderson and Jackson, 2003). In conjunction with other lipid kinases they can generate 
three lipid products, Ptdlns3P, PtdIns(3,4)P2 and PtdIns(3,4,5)P3. The class I PI3- 
kinases are the best characterised and can produce all three phosphorylated 
phosphoinositides but are thought to preferentially phosphorylate Ptdlns(4,5)P2 in vivo 
to give rise to Ptdlns(3,4,5)P3. The class la  group are heterodimeric proteins consisting 
o f a llOkDa catalytic subunit and a adaptor subunit (usually 85kDa). The regulatory 
subunit whilst having no intrinsic catalytic activity contains multiple protein interaction 
domains such as SH3, SH2 and proline rich regions (see section 1.5) that are essential 
for the correct functioning of the P13-kinases. The class lb enzyme comprises a catalytic 
and distinct regulatory subunit (p i01 or p87) that confers G-protein sensitivity. Class 1 
PI3-kinases are primarily activated downstream of Tyr kinase receptors in response to 
growth factor stimulation but they are also activated downstream of integrins, G-protein 
coupled receptors and intracellular Tyr kinases (for review see (Anderson and Jackson, 
2003)). Activation of the kinase is achieved through binding to specific phosphotyrosine 
residues mediated through the p85 SH2 domains. Binding to these residues brings the 
kinase into close proximity of its substrate Ptdlns(4,5)P2 in cellular membranes and
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results in the production o f PtdIns(3,4,5)P3. Signalling events downstream of PI3-kinase 
are regulated through the recruitment to specific areas of the membrane of proteins such 
as phosphoinositide-dependent kinase 1 (PDKl) and protein kinase B (PKB). These 
proteins contain PH domains that bind to PtdIns(3,4,5)P3. (Cantrell, 2001). Once at the 
membrane PDKl is activated and can then phosphorylate multiple downstream targets 
such as PKB that are also recruited to the membrane through lipid interaction domains 
such as PH, PX and FYVE domains. PI3-kinase signalling therefore affects a wide range 
o f cellular activities. In particular PI3-kinase activation is the result of growth factor 
receptor signalling and promotes cell proliferation. However cell growth must be tightly 
regulated and the action of PI3-kinase is opposed by the phosphatase PTEN 
(phosphatase and tensin homolog deleted on chromosome ten). PTEN dephosphorylates 
Ptdlns(3,4,5)p3 at the 3 position o f the inositol ring and so down-regulates P13-kinase 
mediated signalling pathways. Disruption of the PI3-kinase pathway, either by 
inactivation of PTEN or hyperactivation of PI3-kinase, can lead to a cell displaying all 
o f the six hallmarks o f cancer (see section 1.7.1) (Dillon et al., 2007) demonstrating the 
important and diverse roles the pathway plays in controlling cell behaviour.
1.4.2 Phospholipase D
Phospholipases catalyse the hydrolysis of ester bonds in phospholipids and are grouped 
into four classes based on the specific bond that they hydrolyse. They participate in 
signal transduction by giving rise to second messenger molecules (see 1.2). For 
example, activation o f receptor tyrosine kinases by growth factors often results in the 
recruitment and activation o f Phospholipase C (PLC) at the plasma membrane where it 
can hydrolyse its substrate Ptdlns(4,5) P2 to produce the second messengers DAG and 
IP3 (Eyster, 2007). The other eukaryotic classes of phospholipase are PLAl, PLA2 and 
PLD, PLD has particular relevance to the work presented in this thesis (for review see 
(Liscovitch et al., 2000)).
So far two mammalian PLD genes have been identified, PLDl and PLD2, each of which 
has two splice variants. The substrate for PLD is phosphatidylcholine (PtdCho) and the
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action of PLD results in the formation of PtdOH and choline. PtdOH functions as a 
second messenger and can also be converted to DAG, another important second 
messenger, through the action of phosphatidate phosphohydrolase. Little is known about 
cell type expression patterns or the substrate specificities for the different isoforms but 
presumably they have evolved to have different signalling roles (for review (Meier et 
al., 1999)). Both isoforms have a PX and a PH domain (see 1.5) that bind lipids such as 
PtdIns(4,5)P2 to both activate the enzymes and target them to specific membranes. A 
range of agonists have been reported to activate PLD such as insulin (Huang et al., 
2005), PDGF and EGF (Sung et al., 2001). The PLD isoforms particularly PLDl have 
been shown to be activated by small GTPases such as RhoA, Cdc42 and Arf (Henage et 
al., 2006) (Yoon et al., 2006) (Meacci et al., 1999). PLDl has also been shown to be 
activated by PKCa (Henage et al., 2006) and PKNl(Oishi et al., 2001).
PLD signalling has been implicated in cellular processes such as membrane trafficking 
events (Lee et al., 2006a) (Corrotte et al., 2006), reorganisation of the actin cytoskeleton 
(Cross et al., 1996; Ha and Exton, 1993) and shown to have an anti-apoptosis role (Oh et 
al., 2007) (Lee et al., 2006b). O f particular interest to the work presented here PLD 
isoforms have also been shown to play a role in controlling migration. For example in 
MDAMB-231 cells PLD activity increased upon serum withdrawal and this also 
promoted migration and invasion (Zheng et al., 2006). PLD2 was shown to be required 
for LPA induced migration of fibroblasts (Pilquil et al., 2006) and both PLDl and PLD2 
were shown to contribute to the migration of leukocytes (Lehman et al., 2006).
The ability of the PLD isoforms to be involved in multiple signalling processes is 
achieved through regulation of their activity both temporally and spatially. The presence 
of lipid interaction domains means that they can be targeted to specific areas of cell 
membranes where other components of the activated pathway are also found and so the 
signal can be propagated. Protein interaction domains aid the formation of signalling 
complexes at specific cellular locations and these are discussed below.
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Figure 1:3 Illustrative examples of the actions of phospholipases (blue) and PI 
kinases (red).
1.5 Protein interactions
A single protein is often involved in multiple signal transduction pathways within a cell. 
This poses a problem since for an appropriate biological response to a signal to be 
achieved the information flow along a pathway must be correct and this requires each of 
the series o f biochemical reactions being tightly controlled. To achieve this control the 
actions o f enzymes such as kinases and phosphatases are regulated both temporally and 
spatially through interactions with both proteins and lipids to generate signalling 
complexes at distinct cellular locations. These interactions help bring together enzyme 
and substrate in an appropriate cellular location and so aid the flow o f information along 
the signalling pathway.
The use o f modular interaction domains provides a way in which these protein 
interactions can be controlled and signalling pathways integrated. Interaction domains 
tend to consist o f independently folding modules o f 35-150 amino acids that recognise
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specific peptide or lipid motifs. Many proteins contain multiple interaction domains 
allowing them to bind to several partners at once and consequently increasing the 
diversity of signalling pathways they can operate in (reviewed by (Pawson and Nash, 
2003)).
Some common protein interaction domains are the Src-homology-3 (SH3) and WW 
domains that both bind to proline rich regions. Domains that interact with lipids include 
the pleckstrin homology (PH), FYVE, phox homology (PX), and C 1 domains. These 
domains recognise different lipids and are important in targeting proteins to specific 
membrane compartments.
Another group of interaction domains recognise particular post-translational 
modifications ((Sect et al., 2006) for review). Examples of these include Src-homology- 
2 (SH2) and phosphotyrosine-binding (PTB) domains which both bind to particular 
phosphorylated tyrosine sequences. Domains that bind to phospho-serine/threonine 
sequences include some WD40 repeats, 14-3-3 and Forkhead-associated (FHA) 
domains. Domains that recognise PTMs other than phosphorylation include the 
Bromodomain that binds to acetylated lysine residues in target proteins and the TUDOR 
domains that frequently bind to methylated lysine or arginine residues.
Increasingly it is becoming clear that some o f these interaction domains although 
originally described as being either a protein or a lipid recognition domain are able to 
bind to both lipids and protein sequences (see (Balia, 2005) for review). This finding 
adds another level of complexity to the way in which protein complexes are targeted and 
formed to give rise to signal transduction.
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1.6 The cytoskeleton and signalling
The cytoskeleton is a dynamic multiprotein structure that provides support and 
mechanical strength to cells. Through the association with a wide variety o f proteins the 
cytoskeleton also acts as a mechanotransducer, organises organelles and participates in 
vesicle trafficking. The cytoskeleton consists of three types of filaments, these are 
microfilaments (MF), microtubules (MT) and intermediate filaments (IF). The subunit 
proteins of microfilaments and microtubules are actin and tubulin respectively, 
intermediate filaments however are made up a much more diverse range of proteins with 
subunits displaying cell type dependent expression (for review (Herrmann et al., 2007)). 
The cytoskeleton is regulated through the association of scaffolding and catalytic 
proteins (Juliano, 2002) that also serve to interlink the filaments and connect the 
cytoskeleton to the ECM and adjoining cells through adhesions such as desmosomes, 
focal contacts and focal adhesions. Increasingly these contacts through which the 
cytoskeleton is linked to other cells and the ECM are being seen as important in 
allowing the cell to convert mechanical forces into biochemical signalling (Katsumi et 
al., 2004). Many cells are exposed to physical forces, for example, endothelial cells 
undergoing shear stress and cells exposed to hyperosmotic/hypotonic conditions are 
subjected to mechanical force as a result o f cell volume alterations. New techniques 
using optical tweezers have allowed the effect of the local application o f force to be 
examined (Hormeno and Arias-Gonzalez, 2006). The ability of cells to sense force is 
demonstrated by the observations that cells grown on flexible substrates migrate faster 
than on more rigid substrates (Pelham and Wang, 1997). Despite the complex nature and 
regulation o f the cytoskeleton a few key regulators have emerged and the best 
characterised of these are the Rho family GTPases, namely RacI, RhoA and Cdc42.
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1.6.1 Rho GTPases
The Rho GTPases are a distinct family within the superfamily of Ras-related small 
GTPases and are encoded by twenty-two mammalian genes. They act as molecular 
switches cycling between an active GTP-bound form and an inactive GDP-bound form. 
Their activity is controlled by guanine nucleotide exchange factors (GEFs) that catalyse 
the exchange of GDP for GTP and GTPase activating proteins (GAPs) that inactivate 
these switches by stimulating their intrinsic GTPase activity. Many Rho GTPases 
undergo post-translational modifications such as phosphorylation and prénylation and 
also associate with guanine nucleotide dissociation inhibitors (GDIs). This combination 
of control mechanisms functions to localise and control their action and has been 
recently reviewed (Buchsbaum, 2007). It has been calculated that approximately 1% of 
the human genome encodes proteins that either regulate or are regulated by direct 
interaction with Rho GTPases (Jaffe and Hall, 2005). Rho, Rac and Cdc42 are the most 
studied of the Rho GTPases and so far over 50 effector proteins have been identified for 
them. The effectors are a diverse range o f proteins and include serine/threonine kinases 
such as the PKNs (Amano et al., 1996b) (Vincent and Settleman, 1997), scaffold 
proteins for example WASP (Rohatgi et al., 1999) and lipid kinases such as PI3-kinase 
(Bokoch et al., 1996), (Tolias et al., 1995). Through this diverse range of effectors the 
Rho GTPases exert considerable control over cell processes (reviewed by (Jaffe and 
Hall, 2005)) such as polarity, cell division, vesicle trafficking and cell motility. Of 
particular interest to this thesis is the role the Rho GTPases play in regulation of the 
cytoskeleton.
Activation of Rho, Rac or Cdc42 results in distinct effects on the actin cytoskeleton.
Rho activation leads to the assembly of actin/myosin contractile filaments, Rac and 
Cdc42 activation lead to the formation o f protrusive actin rich lamellipodia and 
filopodia respectively (Etienne-Manneville and Hall, 2002). These differing effects on 
the actin cytoskeleton are brought about through distinct controls on actin 
polymerisation and organisation. Whilst Rac and Cdc42 both initiate actin 
polymerisation at the periphery of the cell through the Arp2/3 complex they do so 
through acting on complexes containing different members of the Wiskott-Aldrich 
syndrome (WASP) family proteins (Raftopoulou and Hall, 2004). The Arp2/3 complex
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is heptameric and associates with the sides and perhaps also the ends o f existing actin 
filaments to initiate the formation of new, branched filaments (Millard et al., 2004). Rho 
however initiates actin polymerisation through the activation of formins. The binding of 
formin dimers such as mDial to the plus end of actin filaments prevents the binding of 
capping proteins that normally terminate actin polymerisation and results in linear 
elongation o f actin filaments (for review see (Goode and Eck, 2007)).
The newly formed actin filaments must also be correctly organised and in particular the 
branched filaments formed by Cdc42 must be organised into the unbranched bundles 
found in filopodia. Whilst the mechanism of this is as yet unclear it is fairly well defined 
that Rho-induced assembly of actin/myosin filaments is mediated through Rho-kinase 
(ROCK) inactivating myosin light chain (MLC) phosphatase. This leads to increased 
phosphorylation o f MLC that promotes the actin filament cross-linking activity of 
myosin II (Kimura et al., 1996) (Amano et al., 1996a).
The Rho GTPases can also affect actin dynamics through their effects on cofllin that 
acts to sever and depolymerise actin filaments. Rho family GTPase effectors such as 
ROCK (Rho) and PAKs (Cdc42, Rac) activate LIM kinases that inactivate cofilin via 
phosphorylation and induce cytoskeletal rearrangements (Kuhn et al., 2000).
Rho GTPases can also affect microtubule dynamics which similar to actin filaments 
have intrinsic polarity with a minus end which is usually anchored to the centromere and 
a dynamic plus end which is usually located at the cell periphery. The maintenance of 
cell polarity is essential for directed cell migration and microtubule plus-end binding 
proteins such as CLIP-170 that are localised at the cell cortex play a major role in 
defining cell polarity and cell shape (for review see (Siegrist and Doe, 2007)). CLIP-170 
can interact with the Rho GTPase effector IQGAPI that has been shown to be required 
for cell motility (Mataraza et al., 2003). Recent work from our lab has demonstrated that 
PKNl and PKN3 can phosphorylate CLIP-170 in vitro (Dr Collazos, personal 
communication), it remains to be seen what the in vivo significance o f this is.
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1.7 Signalling and disease
Given the multitude of physiological events that signal transduction pathways control 
and the complex interplay between components o f these pathways it is perhaps not 
surprising that when a small element of a pathway malfunctions disease is often the 
result. Examples of diseases caused by aberrant cell signalling include diabetes and 
cancer. Since cancer is the focus of the work presented in the latter part of this thesis it 
is this disease that I will discuss in further detail.
1.7.1 Hallmarks of cancer.
It has been suggested that there are six essential alterations a cell must undergo to give 
rise to a malignant cancer (Hanahan and Weinberg, 2000). The gain o f these 
characteristics is usually mediated through the hyperactivation of oncogenes and/or the 
inactivation of tumour suppressor genes. More than 100 proto-oncogenes and tumour 
suppressor genes have been identified thus far and their dysregulation affects multiple 
signalling pathways and consequently leads to inappropriate cell behaviour. The 
hallmarks of cancer, important oncogenes and tumour suppressors as well as a 
consideration o f the therapies being developed based on our knowledge so far will now 
be considered.
1) Self-sufficiency in growth signals.
Cells are normally stimulated to proliferate in response to growth factors but cancer 
cells can proliferate independent of normal growth factor signalling. This ability can 
arise either from cells becoming able to produce growth factors, mutation or 
overexpression o f growth factor receptors such as those of the EGFR family or 
alterations in components of the pathways downstream of these receptor (recently 
reviewed (Normanno et al., 2006)). These alterations can result in inappropriate 
activation of the proliferative pathway and hence uncontrolled cell growth.
Growth factor receptors are commonly overexpressed in cancers of the breast and 
therapies have been developed to target these receptors. For example 20-30% o f breast
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cancers express higher than normal levels of human epidermal growth factor receptor 2  
(HER2) and this correlates with a more aggressive tumour type (Berger et al., 1988) 
(Guerin et al., 1988). Herceptin is a monoclonal antibody that recognises HER2 and is 
used in the treatment o f HER2 positive tumours to inhibit HER2 mediated signalling 
events (Eisenhauer, 2001)
2) Insensitivity to growth-inhibitory signals.
In the opposite fashion to above, cells also receive signals that prevent them 
proliferating and for a cancer to develop these signals must be ignored. One of the key 
players in regulation o f cell cycle progression is the retinoblastoma protein (pRb), so 
named because inactivation of both copies of the gene results in cancer o f the retina 
(retinoblastoma). pRb negatively regulates cell cycle progression by binding to the 
transcription factor E2F and preventing the expression of genes required for a cell to 
progress through S phase. To proceed through the G1 checkpoint pRb is phosphorylated 
downstream of cyclinDl activation, (reviewed in (Yamasaki, 2003). These regulatory 
controls are disrupted in the majority of tumours frequently through mutations in 
components of the pathway, loss of expression of pRb or overexpression of cyclinD l.
A better understanding of the nature of the pRb/cyclin pathway in different cell types 
and its contribution to the development of different cancers will be critical if useful 
therapeutics are to be developed.
3) Evasion of programmed cell death (apoptosis).
Apoptosis is essential to maintain a homeostatic balance of cell numbers and to prevent 
cells containing damaged DNA dividing and passing on potentially harmful mutations. 
The tumour suppressor p53 is activated in response to DNA damage and plays a key 
role in arresting the cell cycle to allow time for the DNA damage to be repaired and 
promoting apoptosis if  the DNA damage is too great. Without functional p53 signalling 
a cell can accumulate mutations that will potentially contribute to neoplastic growth.
The importance o f p53 as a tumour suppressor is illustrated by the fact that it is 
defective in at least 50% of human tumours (Levesque and Eastman, 2007).
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Targeting p53 for therapeutic gain in the treatment of cancer has been the focus of much 
research and particular focus has been placed on small molecule compounds that would 
reactivate p53 e.g. PRIMA-1 and CP-31398. As yet though no treatments have made it 
to the clinic (Wiman, 2006).
4) Limitless replicative potential.
Although the processes described thus far would seem to be enough for a programme of 
continuous cell growth it has been found that most if  not all cells can only undergo a 
certain number of cell divisions prior to arriving at a state of senescence (i.e. no more 
replication). This is due to the shortening of the chromosome ends that occurs with 
every cell cycle reaching a critical point where any subsequent shortening due to more 
cell cycles would result in damage to gene encoding areas of the chromosome (for 
review see (Hathcock et al., 2005)). However in approximately 85% of human cancers 
telomere length is maintained (Kelland, 2007). The majority of these cells appear to 
achieve this through high levels of expression of the telomerase enzyme and the result is 
that the cells are effectively immortal. The most advanced telomerase specific therapy is 
GRN163L, an oligonucleotide based molecule that act as a telomerase RNA template 
antagonist and is currently in phase I clinical trials.
5) Sustained angiogenesis.
The formation of new blood vessels is critical if a tumour is to grow above 1 -2mm in 
size, this is because the diffusion of oxygen and nutrients can only occur over a short 
distance (Hanahan and Folkman, 1996). The best understood angiogenesis signal is that 
o f the production of vascular endothelial growth factor (VEGF) by neoplastic cells. 
Surrounding endothelial cells express receptors for VEGF and tumour produced VEGF 
stimulates the formation of new blood vessels that supply the tumour with the oxygen 
and nutrients necessary for further growth (Roy et al., 2006).
Bevacizumab is a monoclonal antibody that has been licensed for use in the treatment of 
colon cancer. Bevacizumab works by binding to VEGF and stopping it from binding to 
the VEGF receptors so inhibiting the signalling required for new blood vessels to form.
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Small molecule inhibitors of the VEGF receptor tyrosine kinases are also being 
developed to try and block the signalling pathways required for angiogenesis (de 
Gramont and Van Cutsem, 2005).
6) Tissue invasion and metastasis.
The ability of tumour cells to break away from the primary tumour site and spread to 
other sites in the body is arguably the most important in terms of prognostic outcome for 
a patient (Spom, 1996). Whilst a benign tumour can grow so large that it disrupts the 
normal functioning of surrounding tissues and organs they can often be surgically 
removed and usually will not return. However the ability of a neoplastic cell to migrate 
out of the primary tumour bulk, invade the extracellular matrix and travel to other 
regions in the body where they can form new tumours makes these metastatic cancers 
hard to treat.
The mechanisms behind tumour cell invasion are not clearly defined but the loss of cell­
cell adhesion appears important as is demonstrated by the loss of E-cadherin expression 
in many aggressive tumour types (Christofori and Semb, 1999). Additionally 
degradation of the surrounding matrix and cell surface receptors by proteases is 
implicated in the ability of cells to move out of the primary tumour site, see (Yoon et al., 
2006) for a review . In particular matrix metalloproteinases (MMPs) are often 
upregulated in malignant tumours but although initial studies on MMP inhibitors were 
promising the results from human clinical trials were disappointing (Coussens et al., 
2002). Therefore focus has again turned to understanding the molecular mechanisms of 
cancer cell motility to guide the development of novel therapeutics.
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1.7.2 Cell motility
Cell motility is important both physiologically, for example in development and in 
migration of immune cells to sites of infection, and pathologically where it results in the 
spread of cancer cells to sites distal to the primary tumour (metastasis). Cell motility 
occurs in several distinct processes that nonetheless have some common features 
(Raftopoulou and Hall, 2004). Chemotaxis is the movement of cells towards a chemical 
signal such as a neutrophil moving towards cytokines released at sites of infection. 
Invasion is the process by which cancer cells move through the surrounding ECM, this 
involves production o f proteases to degrade the matrix o f proteins. In vitro descriptions 
of motility distinguish between movement in 2 -dimensions along a flat surface 
(migration) and 3-dimensions through a matrix o f proteins (invasion).
Despite the different types of cell motility they all have some common requirements to 
achieve forward movement (reviewed in (Friedl and Brocker, 2000)), these are:
1 ) Extension of a leading edge.
2) Formation of new sites of adhesion to the ECM.
3) Cell body contraction.
4) Detachment of adhesions at the rear of the cell.
To achieve these events requires maintenance of cell polarity as well as dynamic 
coordination of focal adhesions and the cytoskeleton to produce the force necessary to 
drive the cell forwards. Although the precise regulation of these processes depends both 
on cell type and the microenvironment some of the general mechanisms that have 
emerged nicely illustrate the concepts of signal transduction previously introduced.
Rac and Cdc42 are both primarily thought to be required at the front o f the cell where 
they promote the formation of lamellipodia and filopodia respectively (Nobes and Hall, 
1995) through the localised polymerisation of actin (see section 1.6.1). One mechanism 
of Rac and Cdc42 activation at the leading edge is thought to be through the action of 
P13-kinases stimulated by ligand binding to cell surface receptors. P13-kinase activation
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results in localised production of PtdIns(3 ,4 ,5 )P3 and recruitment of Rac-GEFs 
containing lipid interaction domains such as PH domains (Welch et al., 2003). 
Concurrent with Rac mediated formation of a leading edge, nascent focal complexes 
must also be formed to provide a link between the ECM, integrins, the cytoskeleton and 
downstream intracellular signalling events. Multiple tyrosine phosphorylation events are 
observed at sites of focal complex formation. The major contributors to this are focal 
adhesion kinase (FAK) and Src family kinases (Mitra and Schlaepfer, 2006). Integrin 
activation results in FAK binding to the cytoplasmic tails o f integrins via its FAT (focal 
adhesion targeting) domain where it becomes phosphorylated at Y397. This creates a 
binding site for Src that then further phosphorylates FAK and other associated proteins. 
FAK contains multiple protein interaction domains that act to recruit SH2 and SH3 
domain containing proteins such as pl30Cas, paxillin and Grb2. These signalling 
complexes can then also activate Rac through recruitment of the bipartite Rac-GEF 
ELMOl/DoeklSO (Lu and Ravichandran, 2006). Interestingly high expression levels of 
ELMOl and Dock 180 have recently been found in invading glioma cells (Jarzynka et 
al., 2007). The co-ordinated actions of Src and FAK are important in regulating the 
formation of focal adhesions both temporally and spatially. This is illustrated by the 
observations that FAK '^ '^  ^cells have enhanced focal adhesions and impaired migration 
(Ilic et al., 1995) whereas transformation of cells by Src is associated with decreased 
adhesion and increased migration (Platek et al., 2004). Phosphatases such as PTP-PEST 
are also involved in the signalling events downstream of integrin activation to enable 
fine control over activities and interactions of the various proteins involved in regulating 
migration (see (Larsen et al., 2003) for review).
The maturation of focal complexes to the larger focal adhesions found towards the 
centre of a migrating cell and production of the contractile force required to retract the 
trailing edge is attributed primarily to the action of Rho. Rho acts through its effector, 
Rho kinase (ROCK), to increase contraction of actinimyosin filaments by increasing the 
phosphorylation of myosin light chain both directly (Amano et al., 1996a) and by 
inhibition of myosin light chain phosphatase (Kimura et al., 1996). The mechanism by 
which Rho activity is suppressed at the leading edge and upregulated towards the centre 
and rear o f migrating cells is not clear but is likely to be controlled through the temporal
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and spatial control of Rho-GEFs and Rho-GAPS such as pl90RhoGAP (Grande-Garcia 
et al., 2007).
Whilst the imaging of cell motility has traditionally been carried out on cells migrating 
in 2 -dimensions it has become increasingly clear that there are fundamental differences 
between 2-D and 3-D cell motility. In order for a cancer to metastasise tumour cells 
must cross tissue barriers and move in 3-dimensions. This requires regulation of the 
ECM and proteases such as MMPs that degrade ECM components were thought to be 
essential to allow tumour cells to invade. However imaging of cells moving through a 3- 
D matrix has revealed that tumour cells are capable of moving through a matrix without 
degrading the matrix. This was shown to be dependent on Rho/ROCK signalling and 
cells had a round morphology with membrane blebs. However cells were also capable o f 
moving through the matrix with an elongated shape and this required Rac rather than 
Rho activity and the action of extracellular proteases (Wyckoff et al., 2006) (Sahai and 
Marshall, 2003). These findings demonstrate the complex nature of cell motility 
regulation.
1.8 Protein kinase C
The importance of kinases in the regulation of signal transduction has been illustrated 
above. A family of Ser/Thr kinases that has diverse roles to play in the regulation of 
many physiological processes is the Protein kinase C (PRC) family. They have been 
reported to have a bewildering array o f functions and it is most likely that although there 
is some redundancy between isoforms the tissue specific expression dictates the relative 
role each isoform plays in any given process, (reviewed by (Mellor and Parker, 1998)). 
The family consists of 12 distinct genes although alternative splicing gives rise to a 
greater number o f proteins. They are characterised by their highly conserved catalytic 
domains and grouped into sub classes based on their regulatory domains. The single 
S.cerevisiae PKC isoform, pkcl, contains all the conserved domains that are associated 
with PKC regulation and mammalian PKC isoforms contain selections of these domains 
(see Figure 1:4).
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The classical PKCs include the a , p, and y isoforms that are activated by 
phosphatidylserine in a calcium dependent manner and are also activated by DAG. The 
novel PKC class consists of Ô, 0, £, and r\ isoforms and are activated by DAG. The i and 
Ç isoforms make up the atypical PKC class and these are both calcium and DAG 
independent. The most recently identified family members make up the Protein kinase N 
(PKN) subfamily and are also known as protein kinase C related kinases (PRKs) (for 
review see (Mukai, 2003)). The PKNs consist of at lease three isoforms (PKNl, PKN 2 
and PKN3) which all have distinct regulatory domains to those of the other PKCs. They 
are activated independently from calcium and DAG but are able to be activated by 
members of the Rho family o f small GTPases.
The differing modes of regulation are determined by the domains found in the N- 
terminal regulatory domain of the PKCs (for a review see (Corbalan-Garcia and Gomez- 
Femandez, 2006)). For example the Cl domain of the cPKCs and nPKCs contribute to 
lipid responsiveness and targets PKCs to membranes through its ability to bind PtdSer 
and DAG. The C 1 domain of the aPKCs however contain only a single zinc-finger like 
motif (the cPKCs and nPKCs contain two) and are not responsive to DAG.
A C2 or C2-like domain is found in all PKC isoforms. The C2 domain is a calcium 
binding domain whereas the C2-like domain does not bind calcium, this explains the 
relative calcium dependence or independence of the PKC classes. The C2 domain is also 
found in other proteins such as synaptotagmin and have been shown to mediate protein- 
protein interactions (Ponting and Parker, 1996). The V3 region represents a flexible 
hinge between the regulatory and catalytic domains that varies considerably between 
PKC isoforms. It is therefore likely that this region contributes to some isoform specific 
functions through distinct protein-protein interactions as has been demonstrated in the 
case of the PKNs (see 1.8.1).
The catalytic domains of PKC family members have a classical bilobal kinase structure 
as seen in the crystal structures o f PKCO and PKCi (Xu et al., 2004) (Messerschmidt et 
al., 2005). In order for the kinase to be maximally active a residue within the kinase 
domain known as the activation loop must be phosphorylated (T-loop phosphorylation) 
and in most cases this seems to be achieved through the action o f PDKl (Le Good et al..
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1998) (Flynn et al., 2000). Isoform specific modes o f regulation therefore ultimately 
control the activity of the kinase through this activation loop phosphorylation that is 
thought to be needed to correctly align catalytic active site residues (Cazaubon and 
Parker, 1993).
C-terminal to the catalytic domain is another variable region termed the V5 region. This 
region contains two further phosphorylation sites that are thought to play a role in 
maintaining PKCs in a stable conformation (Bomancin and Parker, 1997). The TP or 
turn motif is conserved in all PKC family members whereas the hydrophobic site or 
FSY motif is absent in the aPKCs and PKNs. In these PKC family members the serine is 
replaced by an acidic residue (glutamate in the aPKCs and aspartate in the PKNs), these 
substitutions may however mimic phosphorylation. The identity o f the kinases 
responsible for phosphorylation of the TP and FSY sites are the subject of much 
speculation and are often thought to be effected by autophosphorylation.
It has been reported recently that the very C-termini of PKCe and PKN 1 are critical for 
catalytic activity and stability (Zhu et al., 2006) (Lim et al., 2006). In the case of PKNl 
the last seven amino acids were reported to be essential for full lipid responsiveness, 
stability and full activity (Lim et al., 2006) (Lim et al., 2005). The V5 region although 
only approximately 50 amino acids long therefore still plays a vital role in regulation of 
the PKCs. This is perhaps best illustrated by the different functions of the two PKCp 
splice variants that only differ in this V5 region. This region must therefore be 
responsible for any differences observed between them, for example in U937 monocytic 
cells PKCPi localises to microtubules whereas PKCPn is found in secretory granules 
(Kiley and Parker, 1995).
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Figure 1:4 Schematic representation of PKC superfamily domain structures.
1.8.1 PKN subfamily
The PKNs were identified 13 years ago based on their homology to the PKCs (Mukai 
and Ono, 1994) (Palmer et al., 1994). So far three isoforms have been identified PKNl 
(PRKl/PKNa), PKN2 (PRK2/PKNy) and PKN3 (PKNp). PKNl and PKN2 are 
expressed in many tissues (Mukai and Ono, 1994) (Quilliam et al., 1996), PKN3 
meanwhile was undetected in adult tissues but is expressed abundantly in cancer cell 
lines (Oishi et al., 1999). Their catalytic domains are highly homologous to those o f 
other PKC family members as has already been discussed, but they are regulated 
through distinct mechanisms.
Each of the three isoforms contain three repeated domains termed the homology region 
1 (HRla,b,c) or ACC domain (for antiparallel coiled-coil fold). These regions are 
approximately 70 amino acids long and each contain a leucine zipper like sequence. The 
X-ray structure o f H R la in complex with RhoA has been solved (Maesaki et al., 1999)
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and showed that the H Rla domain contains an antiparallel coiled-coil finger domain, the 
solution structure of HRlb also revealed the presence of an antiparallel coiled-coil 
domain (Owen et al., 2003). These HRl domains have been demonstrated to bind 
members of the Rho family of GTPases with varying affinity and nucleotide dependence 
(Vincent and Settleman, 1997) (Owen et al., 2003) (Watanabe et al., 1996) (Amano et 
al., 1996b). The binding o f Rho GTPases has been shown to activate the PKNs and this 
may be achieved partly through release of a inhibitory pseudosubstrate region from the 
catalytic site. The pseudosubstrate sequence of PKNl is found within the H Rla domain 
(amino acids 39-53) (Kitagawa et al., 1996) so Rho GTPase binding could induce a 
conformational change in the protein and an alteration of activity. Additionally further 
C-terminal to the HRl domains is a C2-like domain that although it does not confer 
calcium sensitivity to the kinase has been shown to contain an autoinhibitory region that 
is sensitive to arachidonic acid (Yoshinaga et al., 1999). Although the PKNs can be 
activated by fatty acids and phospholipids such as arachidonic acid, cardiolipin, 
PtdIns(4 ,5 )P2 , PtdIns(3 ,4 ,5 )P3 and LPA in vitro the in vivo significance of this is unclear 
(Mukai et al., 1994) (Peng et al., 1996) (Morrice et al., 1994) (Palmer et al., 1995).
PDKl has been shown to activate PKN 1/2 via phosphorylation of its activation loop site 
in vitro and in vivo (Dong et al., 2000) (Flynn et al., 2000). Rho was shown to control 
the interaction between PKNl and PDKl in endosomes this interaction was independent 
of PI3-kinase but activation loop phosphorylation o f PKNl was inhibited by PI3-kinase 
inhibition (Flynn et al.).
PKN 1 has also been shown to be cleaved in response to apoptosis in cultured cells 
(Takahashi et al.) and after ischemia/reperfusion induced apoptosis of rat retinas 
(Sumioka et al.). In both cases PKNl was found to be cleaved and a catalytic fragment 
corresponding to the catalytic domain generated. This adds another mechanism by 
which PKN 1 is activated however it is not known whether the other PKN isoforms are 
similarly activated by apoptotic induced cleavage.
One of the most striking differences between the PKN isoforms is the presence of one or 
two proline rich regions in the V3 regions of PKN2 and PKN3 respectively. These 
regions have been shown to mediate binding of SH3 domain containing proteins. In the
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case o f PKN2 the scaffolding proteins Nek and Grb4 have been shown to interact with 
this region (Quilliam et al.) (Braverman and Quilliam). Nek and Grb4 both contain an 
SH2 domain that enables them to bind to Tyr phosphorylated residues of kinase 
receptors in response to specific signals such as growth factors (Buday et al., 2002). 
PKN 3 meanwhile has been shown to bind GRAF (GAP for Rho associated with focal 
adhesion kinase) and the related protein GRAF2 (Shibata et al.). The V3 region of 
PKN 1 although it lacks a proline rich region also mediates protein interactions and has 
been shown to interact with TRAF2 (TNFa receptor associated factor 2) and contribute 
to activation o f NFkB signalling (Gotoh et al., 2004). Isoform specific protein-protein 
interactions such as these therefore contribute to the assembly of distinct signalling 
complexes in response to different upstream signals.
Like other kinases the regulation of PKN activity must be tightly controlled both 
temporally and spatially. For example the PKNs have been shown in several contexts to 
play a role in controlling the cell cycle and in particular the timing of the transition from 
G2 to M phase. In Xenopus cycling egg extracts and vascular smooth muscle cells 
(VSMCs) PKNl phosphorylates the phosphatase Cdc25C. This results in an inhibition 
o f Cdc25C activity and a delay to mitosis due to a delay in the Cdc2/cyclinBl complex 
being activated by dephosphorylation. In the VSMCs this delay in mitosis was mediated 
by Rho and PKNl and occurred in response to TGFpl treatment (Su et al.) (Misaki et 
al.). In HeLa S3 cells PKN2 was shown to be regulated by Rho GTPases and control 
both entry into mitosis and abscission of the midbody to complete cytokinesis. In this 
system PKN2 was required to phosphorylate and activate Cdc25B, the phosphatase 
required to activate the cyclin/Cdkl complex and promote G2 to M progression 
(Schmidt et al., 2007).
An example o f the spatial control o f a PKN isoform comes from work in our lab that 
demonstrated that ectopically expressed PKN 1 translocated in a reversible manner to 
punctate structures in response to hyperosmotic stress, this behaviour was dependent on 
Racl. PDKl was also recruited to these structures and consistent with this PKNl was 
seen to undergo activation loop phosphorylation in response to hyperosmotic stress.
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Sensing the osmolarity of the environment is critical for all organisms and they have 
evolved mechanisms to cope with either hyper or hypo osmotic conditions (reviewed in 
(Bourque et al., 1994)). Changes in osmolarity are detected by osmosensors that then 
activate a variety of signalling cascades. Protein families activated in response to 
hyperosmolarity include members of the Rho GTPases (Di Ciano et al., 2002) (Di 
Ciano-Oliveira et al., 2003), the MAPkinases (Galcheva-Gargova et al., 1994), (Han et 
al., 1994) (Matsuda et al., 1995), PKCs (Zhuang et al., 2000) and src family kinases 
(Reinehr et al., 2004), (Volonté et al., 2001). In contrast to PKNl, PKB has been shown 
to be down-regulated in response to hyperosmolarity (Meier et al., 1998). These 
signalling pathways cause a variety of rapid post-translational and slower transcriptional 
changes that help restore cell volume, reinforce the cytoskeletal architecture and delay 
the cell cycle. All these adaptations help cells to survive transient increases in 
osmolarity.
As a consequence of hyperosmolarity changes in gene expression occur, for example the 
activation of the transcription factor OREBP allows accumulation of compatible 
osmolytes that help restore cell volume (Ko et al., 2000). Interestingly there have been 
several reports of PKN 1 controlling transcriptional activity. PKN 1 has been shown to 
interact with the NDRF/NeuroD2 transcription factor (Shibata et al., 1999) and to 
activate promoters responsible for smooth muscle cell differentiation in response to 
TGF-P (Deaton et al., 2005) or starvation (Cottone et al.). PKNl was also shown to 
translocate from the cytoplasm to the nucleus in response to heat stress suggesting a role 
for PKN 1 in control of transcriptional responses under this stress condition (Mukai et 
al., 1996a). Additionally PKNl has been shown to induce transcriptional activation of 
the androgen receptor (Metzger et al.) and act downstream of Rho to drive activity of the 
serum responsive element of the c-fos gene promoter (Morissette et al.) and the c-jun 
promoter (Marinissen et al., 2001).
The PKN I dependent effects on c-jun gene expression were shown to be mediated 
through a signalling pathway involving MKK3/MKK6 and p38y hence linking PKNl to 
regulation of this mitogen activated protein kinase (MAPK) signalling cascade. Further 
linking PKN 1 to the p38 pathway is the finding that PKN I is able to phosphorylate 
MLTKalpha (MLK like mitogen activated triple kinase), a MAPK kinase kinase for the
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p38 pathway. Interestingly the expression of dominant negative PKNl inhibited the 
phosphorylation of MLTKalpha in response to hyperosmotic shock (Takahashi et al.).
Another consequence of hyperosmolarity is remodelling of the cytoskeleton that 
presumably occurs to help cells withstand the mechanical stress that results from cells 
shrinkage due to an efflux of water. Changes in the cytoskeleton include an increase in F 
actin content and organisation mediated at least in part by Rac and Cdc42 (Di Ciano et 
al., 2002). Prehaps not surprisingly considering their control by Rho GTPases the PKNs 
have been linked numerous times to the cytoskeleton. PKN 1 has been shown to interact 
with a-actinin in vivo and this interaction was stimulated by PtdIns(4 ,5 )P2 in vitro 
(Mukai et al.). Endogenous a-actinin and PKN 1 were also shown to interact in platelets 
and this interaction is greatly increased in response to pathological shear stress (Feng et 
al.). Further links between PKNs and the dynamic actin cytoskeleton have been made 
through overexpression studies. Expression of wild type PKN 1 was found to induce 
membrane ruffling and actin cytoskeleton reorganisation mimicking the rearrangements 
seen in response to insulin stimulation. Expression of kinase dead forms of PKNl 
however prevented the rearrangements of the actin cytoskeleton usually observed in 
response to insulin stimulation (Dong et al.). This is particularly interesting since 
hyperosmolarity, like insulin stimulation, induces phosphorylation o f the insulin 
receptor (Ouwens et al., 2001). PKNl has also been implicated downstream of Rho in 
regulating GLUT4 dynamics and glucose uptake in response to insulin (Standaert et al., 
1998) and so it appears that PKNl may have roles to play in both insulin and 
hyperosmotic induced signalling pathways. Further evidence for PKN regulation of the 
cytoskeleton comes from reports that PKN 1 is able to interact with and phosphorylate 
the head domains of the intermediate filament proteins vimentin, glial fibrillary acidic 
protein (GFAP) and neurofilaments in vitro and so inhibit filament formation 
(Matsuzawa et al.) (Mukai et al., 1996b).
Previously the importance o f regulation of the cytoskeleton to achieve cell motility was 
discussed and perhaps not surprisingly given their status as Rho GTPase effectors PKNs 
have been implicated in elements of cell motility. The activation of Racl by the ECM 
constituent hyaluronan (HA) binding to the CD44 receptor results in activation of PKN2
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and enhanced migration o f astrocytes (Bourguignon et al.). PKN2 has also been shown 
to bind to the transmembrane phosphatase PTB-BL that has been linked to cytoskeletal 
rearrangements and they were found to colocalise in lamelliopodia structures (Gross et 
al., 2001). Lamellipodia must be dynamically regulated to enable cell migration and it is 
possible that the PKN2 interaction with PTB-BL helps achieve this regulation. The 
regulation of cell-cell adhesions is essential for the proper establishment and 
maintenance of organised tissues, and pathologically the ability of cells to disrupt 
contacts with neighbouring cells is associated with greater metastastic potential. PKN2 
has been implicated in the control of cell-cell adhesion in kératinocytes by operating 
downstream of Rho and inducing phosphorylation of Fyn and catenins to enhance 
adhesion (Calautti et al.). The role of PKN2 in cell migration therefore appears to 
depend on the cell type examined since the formation of strong cell-cell adhesions is 
generally associated with decreased adhesion whereas in the astrocyte model PKN2 
activity enhanced migration. PKN3 has been shown to be required for the metastasis of 
PC3 cells in an orthotopic mouse tumour model implicating a role for PKN3 in 
controlling cell invasion (Leenders et al.).
In conclusion it is apparent that the PKNs are important regulators of cell behaviour that 
participate in multiple signalling pathways. Interactions with protein and lipid partners 
regulate their participation in signalling downstream of specific signals by controlling 
both their location and activity within the cell. The PKNs status as Rho GTPase 
effectors links them to control o f the cytoskeleton and a role for the PKNs in cell 
motility is just beginning to emerge with PKN2 and PKN3 implicated in migration and 
invasion respectively. This work seeks to further our knowledge both o f the spatial 
control and functional roles of PKN I .
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Chapter 2 
Materials and Methods
2 Materials
2.1 Chemicals and plasticware
PfuTurbo DNA Polymerase was from Stratagene.
Optimem was from Gibco.
NuPAGE Bis-Tris gels, Lipofectamine 2000, Agarose was from Invitrogen.
HiPerFect was from Qiagen.
Ethanol and Methanol were from Fisher.
Transwell inserts with 8 pm pores were from Coming.
BD Biocoat Matrigel Invasion chambers were from BD Biosciences.
T4 DNA ligase and restriction enzymes were from NEB.
Rainbow protein markers, hyperfilm, ECL and ECLplus were from Amersham- 
Pharmacia.
Phalloidin-Alexa546 was from Molecular Probes,
PVDF membrane was from Millipore.
MOWIOL 4-88 was from Calbiochem.
HPLC grade toluene, chloroform, methanol and water were from Rathbum Chemicals 
Ltd.
Phosphoinositides: PI(3)P (diC16, H^), PI(4)P (diC16, H^), PI(5)P (diC16, H^),
PI(3 ,4 )P2 (diC16, H^), PI(3 ,5 )P2 (diC16, H^), PI(4 ,5 )P2 (diC16, H^) and PI(3 ,4 ,5 )P3 
(diC16, H^) were from Cell Signals. diC16 Ptdlns (monosodium salt) was from Echelon 
Biosciences Inc.
Phospholipids: l,2-dilauroyl-sn-glycero-3-phosphocholine (DPLC), 1,2-dilauroyl-sn- 
glycero-3-phosphoethanolamine (DPLE), 1,2-dilauroyl-sn-gIycero-3-[phospho-L-serine] 
(sodium salt) (DPLS), l,2-dilauroyl-sn-glycero-3-phosphate (monosodium salt)
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(DPLA), l,2-dilauroyl-sn-glycero-3-[phospho-rac-(l-glycerol)} (sodium salt) (DPLG) 
were from Avanti Polar Lipids Inc.
All other reagents were purchased from Sigma-Aldrich.
All glassware supplied by CR-UK research services except 5ml chromacol screw-top 
vials and specimen tubes (soda glass with polyethylene stoppers) were from VWR 
International.
Plasticware was purchased from Eppendorf, Coming, BD Falcon, Sterilin and Scientific 
Specialities.
2.2 Buffers
2 X LDS sample buffer
50% (v/v) 4 X LDS sample buffer (Invitrogen).
MOWIOL mounting solution
10% (w/v) Mowiol 4-88, 25% (v/v) glycerol, lOOmM Tris pH 8.5. Incubate for 10 hrs 
at 50°C and mix thoroughly.
LB (Agar)
Provided by CR-UK research services. lOg/1 Bacto-Tryptone, 5g/l yeast extract, lOg/1 
NaCl (6 g agar/400ml LB).
PBS free)
Provided by CR-UK research services 8 g/l NaCl, 0.25g/l KCl, 1.43g/l Na2HPÜ4, 0.25g/l
KH2PO4, pH 7.2
TBS-T
20mM Tris pH 7.5, 0.9% (w/v) NaCl, 0.1% (v/v) Tween-20.
TAE
0.04M Tris, 0.1% glacial acetic acid, ImM EDTA pH 8  
Transfer buffer
20mM Trizma base, 200mM Glycine, 10% MeOH.
5 X Trypsin/Versene
Provided by CR-UK research services. 0.25% trypsin in Versene, pH 7.2: filter 
sterilised.
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DMEM
Dulbecco’s MEM (DMEM) was from CR-UK research services and was endotoxin free.
2.3 Antibodies
Name Source Antigen Description Use Dilution
PKNl Transduction
Laboratories
PKNl Mouse
monoclonal
Immuno-blot (IB) 1 : 1 0 0 0
PKN2 Transduction
Laboratories
PKN2 Mouse
monoclonal
IB 1 : 1 0 0 0
PKN3 In house PKN3 Rabbit
monoclonal
IB 1 : 2 0 0
GFP-3E1 CR-UK GFP Mouse
monoclonal
IB 1 : 1 0 0 0
Tubulin Sigma Tubulin Mouse
monoclonal
IB 1:5000
Mouse-
HRP
Amersham Mouse
IgG
HRP-
linked
secondary
IB-2° antibody 1:5000
Rabbit-HRP Amersham Rabbit
IgG
HRP- 
1 inked 
secondary
IB-2® antibody 1:5000
AlexaFluor-
488
(Donkey)
Molecular
Probes
Mouse
IgG
Flourescent
secondary
Immunoflouresence 1:500
2.4 Cell types
MDAMB-468, MDAMB-231, MCF7, A459, CALU-1, HI299, PC3, LNCAP, 
C 0L0741, HT29, COLO320HSR and HEPG2 human transformed cell lines and 
NIH3T3 cells were from CR-UK cell production services.
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786-0, A-498, Caki-1, SK-HEP-1, ACHN transformed human cell lines were obtained 
from the ATCC. GFP, GFP-PLDla, GFP-PLDlb and GFP-PLD2 expressing stable 
polyclonal MDAMB-468 cells were generated by selection of expressing cells post­
transfection with lOOpg/ml G418. Resistant cells were then sorted using a FACS sterile 
sort to separate green cells and these were continued in culture in the presence of 
500pg/ml G418.
Cells were maintained under conditions recommended by CR-UK cell production 
services but typically were split 1:4 every 3 days and maintained in DMEM + 10% FCS.
2.5 Constructs
Name Source Expression vector
GFP-PKNl Dr Neil Torbett (Torbett et al., 2003) pEGFP-Cl (Clontech)
DsRed-PKNl Dr Neil Torbett (Torbett et al., 2003) pDS-RED-Cl (Clontech)
GFP-PKNl CD See section 2.6.1.8 pEGFP-Cl
GFP-PKC; CD See section 2.6 .1.8 pEGFP-Cl
GFP-Chimera 1 See section 2.6 .1.8 pEGFP-Cl
GFP-Chimera 2 See section 2.6.1.8 pEGFP-Cl
GFP-Chimera 3 See section 2.6 .1.8 pEGFP-Cl
GFP-Chimera 2.1 See section 2.6.1.8 pEGFP-Cl
GFP-Chimera 2.2 See section 2.6.1.8 pEGFP-Cl
GFP-Chimera 2.3 See section 2.6 .1.8 pEGFP-Cl
GFP-49aa See section 2.6 .1.8 pEGFP-Cl
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2.6 Methods
2.6.1 Molecular biology
2.6.1.1 PCR reactions
Polymerase chain reactions (PCRs) were performed using a DNA Engine DYAD (MJ 
Research). The reaction mix contained: lU Pfu Turbo, 1 x Pfu buffer, 0.4mM ultrapure 
deoxynucleotide triphosphate mix (0.4mM of each dNTP), 5% DMSO, 1 pM sense 
primer, IpM antisense primer and lOOng DNA template. Reactions were made up to 
50pl in distilled water. PCRs were carried out using the following programme:
Step 1: 95°C, 2 mins.
Step2: 95°C, 45 secs.
Step 3: (Lowest primer Tm -4) °C, 45 secs.
Step 4: 72° C, (length of product in bps/500)mins.
Step 5: Cycle back to Step 2x35 .
Step 6 : 4°C, forever.
PCR products were examined by agarose gel electrophoresis and purified using the 
QIAquick gel extraction kit (Qiagen).
2.6.1.2 Agarose gel electrophoresis
Samples were 5:1 in 6  x DNA loading buffer and separated on a 1% agarose gel in 1 x 
TAB buffer alongside Ikb ladder DNA markers. 4% (v/v) ethidium bromide was added 
to the gel to allow visualisation of DNA on a transilluminator. Bands were excised and 
DNA extracted and purified for subsequent cloning using the QIAquick gel extraction 
kit (Qiagen).
2.6.1.3 Restriction digests
Restriction digests were carried out following the manufacturers guidelines.
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2.6.1.4 Ligation reactions
Ligation reactions were performed using T4 DNA ligase . The reaction mix contained 
400U T4 DNA ligase, 1 x ligase buffer, lOOng digested vector and insert DNA. 
Typically approximately a 3:1 molar ratio of insert:vector was used and a “vector only” 
control carried out in parallel. Ligation reactions were performed for at least 1 hr at 
16°C.
2.6.1.5 Transformation of E.coli
Chemically competent DH5a or RapidTrans TAMl (Active Motif) E.coli were 
transformed with purified plamids or ligation reaction products by heat shock. 50pl of 
competent cells were mixed with lOOng plasmid DNA or 3 pi ligation reaction and 
incubated on ice for 30 mins. Cells were heat shocked at 42^C for 45 secs and then 
placed on ice for 2 mins. 500pl LB was added and the transformation mixtures were 
incubated with shaking at 37°C for 1 hr. Cells were plated onto LB plates containing the 
appropriate selection antibiotic (100 pg/ml ampicillin or 25 pg/ml kanamycin). Plates 
were inverted and incubated at 37°C overnight.
2.6.1.6 Plasmid DNA preparation
A colony from transformed DH5a cells was picked and grown overnight in a 5ml 
culture of LB containing the relevant selection antibiotic. From this small scale DNA 
preparations were carried out using the Qiagen mini-prep kit. For large scale DNA 
purifications a 5ml overnight culture was used to inoculate a 200ml culture and after 
another overnight incubation DNA was prepared using the Qiagen plasmid maxi-prep 
kit. The concentration and quality of DNA produced was measured using Nanodrop 
ND-1000 UV-Vis Spectrophotometer. The quality o f the DNA was considered 
acceptable if the OD260 /OD280 ratio was in the range 1.6-1.8.
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2.6.1.7 DNA sequencing
DNA sequencing was carried out using the ABI BigDye Terminator v3.1 system and 
following the manufacturers protocol. The reaction mix typically comprised 150ng 
plasmid, 3.2pmol primer and 1 x BigDye Terminator Mix in Sequencing Buffer 
(supplied by CR-UK services) made up to a final volume of 20pl in distilled water. 
Cycle sequencing was performed using the following programme:
Step 1 : Ramp to 96°C at 2.5 °C/sec.
Step 2: 9 6 T , 1 min.
Step 3: 96°C, 10 secs.
Step 4: Ramp to (primer Tm -3) °C at l°C/sec.
Step 5: (primer Tm -3)°C, 5 secs.
Step 6 : Ramp to 60°C at 1 °C/sec 
Step 7: 60°C, 4 mins.
Step 8 : Cycle back to Step 3 x 24.
Step 9: 2°C, forever.
Reaction products were purified using DyeEx 2.0 Spin Kits (Qiagen) and sequenced by 
CR-UK services on an Applied Biosytems 3730 DNA Analyser. Sequencing results 
were opened with EditView software and analysed using the DNA Strider package and 
NCBI Blast.
2.6.1.8 Construction of GFP-PKNI/PKCzeta chimeras
GFP-PKNl CD, GFP-PKCzeta CD, GFP-Cl, GFP-C2 and GFP-C3 were generated by 
amplification o f myc-tagged chimeras in pcDNA3.1/Hygro (+) previously created by Dr 
Iturrioz. Sequences were amplified using the following primers:
Sense: 5’-CCGCTCGAGCGATGCCGGAGCAGAAGCTGATATCC-3’
Antisense: 5 -TAGAAGGCACAGTCGAGG-3'
The sense primer incorporated a restriction site for Xhol to allow the PCR products to 
be cloned into pEGFP-Cl (Clontech) between the Xhol and Apal MCS sites. This
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resulted in the fusion o f an N-terminal GFP tag in frame with the myc tagged 
PKN 1/PKCzeta chimeras.
GFP-C2.1 GFP-C2.2 and GFP-C2.3 were generated using a 2-step overlapping PCR 
cloning strategy, the external primers in all cases were as above and PCR products from 
the second round of PCR were cloned into pEGFP-C 1 (Clontech) between the Xho 1 and 
Apal MCS sites as before.
Internal primers were as follows:
GFP-C2.1:
Sense5’-GTTACAGGGACCTGAAGTTGGACAACGTCCTCCTCGATGCC-3’ 
Antisense 5 ’-GGCATCGAGGAGGACGTTGTCCAACTTCAGGTCCCTGTAAAC-3 ’ 
GFP-C2.2:
Sense 5 ’-GCTGTGGACTGGTGGGGACTGGGTGTCCTTATGTTTGAG-3 ’
Antisense 5’-CTCAAACATAAGGACACCCAGTCCCCACCAGTCCACAGC-3” 
GFP-C2.3:
Sense 5 -CGCTACCCCCGCTTCCTGTCGGTCAAGGCCTCACACGTCTTG-3 '
Antisense 5 ’-CAAGACGTGTGAGGCCTTGACCGACAGGAAGCGGGGGTAGC-3 ’
For the first round of PCR:
A sense internal primer was combined with an antisense external primer and the 
template DNA used was GFP-PKCzeta CD.
An antisense internal primer was combined with a sense external primer and the 
template DNA used was GFP-PKN1 CD.
GFP-49aa was generated with the following primers using GFP-PKN 1 CD as a template 
and again incorporated a Xhol and Apal restriction site at the 5’ and 3’ ends 
respectively o f the PCR product. The resulting PCR product was cloned into pEGFP- 
C1 to give an N-terminal GFP tag in frame with the PKNl peptide sequence.
Sense 5’-CCCGCTCGAGCGGCCGCCGCCGCCGGTGGGGACCTGATGCTGCACA 
TCCAC-3’
Antisense 5’-CGCGATGGGCCCCTAGAGCAAATTGTCCAACTTCAGGTCCCTGT
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A-3’
2.6.2 Confocal Microscopy
Cells were seeded on acid washed coverslips and transfected and stimulated as indicated 
in figure legends. After stimulation cells were washed once with PBS and fixed in 4% 
(w/v) paraformaldehyde/PBS for 10 mins at RT. When staining for 
immunoflourescence the following procedure was followed:
1) Aldehyde functions were quenched with 50mM NH4CI for 10 mins.
2) Cells were permeabilised and non-specific sites blocked with 0.1% Triton-X- 
100, 2% BSA (bovine serum albumin) (v/v) in PBS for 15 mins.
3) Incubated in primary antibody for 1 hour. To visualise the actin cytoskeleton 
phalloidin-Alexa546 (Molecular Probes) was used in place of primary and 
secondary antibodies. Antibodies/phalloidin-Alexa546 were used at a 1:200 and 
diluted in PBS containing 2% BSA.
4) Coverslips were washed three times in PBS.
5) Incubated in dye-conjugated secondary antibody for I hour shielded from light. 
Antibodies were used at 1:500 diluted in PBS containing 2% BSA.
6 ) Coverslips were washed three times in PBS and then washed once in water.
7) Coverslips were mounted on glass slides under MOWIOL (lOOmM TrisHCl pH 
8 .8 , 10% (w/v) MOWIOL 4-88 (Calbiochem) and 25% (v/v) glycerol) 
containing anti-photobleaching agent (2.5% (w/v) 1,4- 
diazabicyclo[2.2.2]octane). Slides were incubated at 37® C for I hr to allow 
MOWIOL to set. Slides were washed and stored at 4°C.
Slides were examined using a confocal laser scanning microscope (Axioplan2 with 
LSM510 software, Carl Zeiss Inc.) equipped with a 63x/1.4 Plan-APOCHROMAT oil 
immersion objective. GFP and AlexaFluor-488 (Molecular Probes) were excited with 
488nm line of an Argon laser. RFP and Alexa546 were excited with 543nm line of a 
Helium-neon laser. Individual channels were scanned sequentially to prevent bleed 
through. Each image represents a single 1pm ‘Z ’ optical section and is representative of 
at least 1 0  fields o f cells and at least three separate experiments.
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2.7 Polyacrylamide gel electrophoresis (SDS- 
PAGE)
Cell lysate samples were prepared in NuPAGE LDS sample buffer 0.2M DTT, heated at 
90°C for 10 mins and briefly sonicated to shear genomic DNA. Samples were run on 
NuPAGE 4-12% gels with MOPS SDS Running Buffer containing NuPAGE 
Antioxidant at 200V (constant). RPN800 Full Range Rainbow Markers were run 
alongside each set of samples.
2.7.1 Western blotting
Proteins separated on NuPAGE gels were transferred electrophoretically onto 
polyvinylidene difluoride membrane (PVDF). A wet transfer system using Biorad 
apparatus was used and all transfers were performed at 4°C at constant voltage and 
400mA/hour. After transfer membranes were blocked by incubation at RT for 1 hour in 
3% (v/v) BSA/TBS-T and then incubated overnight at 4°C in primary antibody diluted 
1:1000 in 3% (v/v) BSA/TBS-T. Membranes were washed 3 x 20 minutes in TBS-T 
followed by incubation with the relevant secondary antibody diluted 1:5000 in 3% (v/v) 
BSA/TBS-T. Membranes were washed 3 x 20 minutes in TBS-T and developed using 
enhanced chemiluminesence (ECL) or ECLplus according to the manufacturers 
guidelines and exposed to Flyperfilm.
2.7.2 Biomolecular modelling
Protein sequences were obtained from NCBI collection, accession numbers; PKCÔ 
NP 006248; PKC^ NP 002735; PKNl NP 002732. These sequences were aligned in 
the programme ClustalX to allow the equivalent residues of PKN 1 aa699-747 to be 
found in the PKC(!^  and PKCÔ kinase domains. This was then used to highlight the 
appropriate amino acids in the crystal structure of the PKC0 kinase domain (solved by 
(Xu et al., 2004)) in the programme SwissModel.
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2.7.3 Cell assays and transfection
2.7.3.1 Transfection of plasmid DNA
Transient transfections were performed using Lipofectamine 2000 and following the 
manufacturers guidelines. DNA/Lipofectamine complexes were prepared in Optimem 
and added directly to the culture medium. 6  hrs post transfection the media was 
refreshed and subsequent manipulations were typically performed 48 hrs post­
transfection.
2.7 3.2 Transfection of sIRNA oligos
HiPerFect reagent was used to achieve knockdown o f PKN isoforms using targeted 
siRNA oligos. Complexes were prepared in DMEM in the absence o f serum and oligos 
targeting PKN isoforms were used at 5nM each. An oligo targeting luciferase was used 
as a control in all experiments and also to balance the concentrations of oligos used so 
that in all cases the final concentration of oligo was 15nM. Complexes were added to 
cells dropwise and incubated under normal growth conditions for 24 hrs after which 
time the media was replaced. All assays were carried out 48-72 hrs post-transfection. 
OLIGOS:
NAME TARGET DNA SEQUENCE
LUC control AATCGAAGTATTCCGCGTACG
PKN 1 a A AGGGCACGGG A ACTGG AGTT
PKN lb  AACTGGAGTTGGCTGTGTTCT
PKN2 (PKN2-3) AAGCATGGCATGTGTCTCTATT 
PKN3 (GB3) GAGAGCCTGTACTGCGAGAAG
2.7 3.3 Hyperosmotic stress
Transiently transfected cells were subjected to hyperosmotic conditions 48 hrs post­
transfection for 30 mins by the addition of DMEM containing 0.4M sucrose or 0.5M 
urea and 25mM Hepes pH7.2. This is equivalent to an increase in osmolarity from 340
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mOsmol/kg to 740 mOsmol/kg. After 30 mins the cells were washed quickly with cold 
PBS and then fixed with 4% (w/v) PFA in PBS. The osmolarity of media was measured 
using an Osmomat 030 cyoscopic osmometer.
2.7.5.4 Cell fractionation
NIH3T3 cells were transiently transfected (see 2.7.3.1) with plasmids as descibed in 
figure legends. 48 hours post transfection cell manipulations were performed to examine 
the cellular distribution o f endogenous and over-expressed proteins.
2.7.3.4.1 Cellular distribution and solubility of PKN1
N1H3T3 cells were transfected in 6  well plates and subsequently harvested in 200pl of 
digitonin buffer (0.05% digitonin, 50mM TrisHCl pH7.5, ISOmM NaCl and 1 Complete 
protease inhibitor tablet per 50ml). Samples were tumbled at 4°C for 30 minutes and 
then spun at MOOOrpm in a bench top centrifuge for 15 minutes. The supematent was 
removed and LDS sample buffer added. The pellet was resuspended in 200|l i 1 of Triton- 
X-100 buffer (0.5% T-X-lOO, 50mM TrisHCl pH7.5, 150mM NaCl and 1 Complete 
protease inhibitor tablet per 50ml) and the samples were tumbled at 4°C for 30 minutes 
and then spun at MOOOrpm in a bench top centrifuge for 15 minutes. The supematent 
was removed and LDS sample buffer was added to both the supematent and the pellet 
samples. All samples were analysed by westem blot to examine the distribution o f the 
GFP-tagged chimeric proteins (see figure legends).
2.7.3.4 2 Sucrose gradient
15cm dishes o f transfected NIH3T3 cells were washed with cold PBS and harvested in 
1ml of homogenisation buffer (0.25M sucrose, lOmM Hepes-KOH pH7.2, ImM EDTA 
pH7.5, ImM MgAc and 1 Complete protease inhibitor tablet per 50ml). Samples were 
homogenised using a cell cracker (EMBL) and spun at 3200rpm for 7 minutes in a 
bench top centrifuge at 4°C. The pellet was retained for analysis o f protein composition 
by westem blot and the supematent was loaded onto a 1 2 ml sucrose gradient ranging
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from 0.3M to 1.2M sucrose and this was spun at 26000 rpm for 18 hours. 1ml fractions 
from the gradient were then collected and sample buffer added prior to protein 
distribution being analysed by westem blot.
2.7.3 5 Scratch wound assay
Wounds were created in a confluent monolayer of cells by gently scraping the surface 
with a Gilson D200 pipette tip. After the wound was created the media was replaced 
with DMEM + 10% FCS, if filming was going to be performed the media also contained 
25mM Hepes pH 7.2. For filming scratch wound assays were performed in 24-well 
plates 72 hrs post-transfection with siRNA oligos and a single vertical wound was made 
in each well. Plates were sealed around the edge and a small hole made in the side to 
allow a needle to be inserted through which CO2 was blown. A lowlight microscope with 
moving stage and heat box was used to follow the wound closure over 24 hrs. A 5x 
phase objective was used and a picture taken every 15 mins. After the acquisition had 
finished the cells were harvested by removing the media, washing once with warm PBS 
and the adding 50pl 2 x LDS Sample buffer to each well and westem blots were 
performed to confirm successful knockdown of PKN isoforms. The pictures were 
analysed with MetaMorph software to calculate the area of each wound at each time 
point up to the point o f complete closure of the wound. These values were used to give 
an arbitary speed of migration for each transfection condition and an average o f the 
replicates (at least three) was calculated.
For the multiple scratch wound assays used to analyse the PtdOH content by LC- 
MS/MS, 15cm confluent dishes of cells were either wounded with 20 vertical and 20 
horizontal scratches or left unwounded. In each case the media was replaced at the point 
of wounding and cells were incubated under normal growth conditions for 4 hrs. After 4 
hrs plates were placed on ice, media was removed and cells were washed once with cold 
PBS. The PBS was removed and the cells were scraped to harvest and snap frozen on 
dry ice in pre-chilled silanated glassware. Samples were stored at -80®C until lipid 
extractions were performed (see 2.7.4).
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2.7.3 6 Alcohol trap assay
Confluent wells of cells were incubated in either DMEM + 10% FCS containing either 
1% EtOH, 0.1% BtOH or 0.1% Bt-2-OH for 1 hr at 37^C, 5% CO2. Wounds in the 
confluent layer of cells were created as before and the media replaced with warm 
DMEM + 10%FCS containing the appropriate alcohol. Filming of the wounds and 
measurement of the speed o f migration was as described in 2.7.3.5
2.7.S.7 Boyden chamber migration assay
The underside of Transwell inserts (Coming) were coated with either lOpg/ml laminin 
(from human placenta-Sigma L6274), 25pg/ml fibronectin (from bovine plasma-Sigma 
FI 141) or 50pg/ml collagen (from calf skin-Sigma C8919). These coatings were 
performed overnight at 4°C and then the membranes were washed and blocked in 0.1% 
BSA for 1 hr at RT. The membranes were washed again with PBS and placed into fresh 
wells of a 24 well plate and used immediately.
72 hrs post-transfection with siRNA oligos cells were harvested by trypsin treatment and 
resuspended in DMEM + 10%FCS. The number of viable cells for each sample was 
counted using a Beckman Coulter Counter. An equal number of viable cells from each 
transfection condition were pelleted by centrifugation at lOOOg for 5 mins. The cell 
pellet was gently resuspended in DMEM +1%  FCS to a final concentration of 4 x lO'^  
cells/ml. 500pi of DMEM + 10%FCS was placed in the bottom of each well o f the plate 
and SOOpl o f cell suspension (i.e. 2 x 10"^  cells) was added to the upper chamber o f each 
Transwell insert, another sample of cells were taken to analyse the efficiency of 
knockdown by westem blot.
The plates were incubated at 37^C, 5% CO2 for 5 hrs. After 5 hrs cells remaining in the 
upper chamber of the Transwell insert were removed by gently cleaning the upper 
surface of the membrane with a damp cotton bud and washing once in PBS. Cells on the 
lower surface of the Transwell membrane were fixed in 4% PFA. Cells were 
permeabilised with 0.1% T-X-lOO in PBS for 10 mins, stained with DAPI (1:10000 
dilution of bisBenzimide H33342 trihydrochloride (Sigma B2261) in PBS) for 5 mins 
and inserts were washed x 3 with PBS. The extent o f cell migration was calculated by
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counting o f cells on the lower surface of the membrane. This was achieved using a 
Discovery microscope to take nine pictures of each membrane, these pictures were 
analysed using Metamorph software and journals to count the number of nuclei in each 
picture.
2.7.3.S Boyden chamber invasion assay
0.5ml of warm DMEM was added to each BD BioCoat Growth Factor Reduced 
MATRIGEL Invasion Chamber and the matrix was allowed to rehydrate for 2 hrs at 
37^C, 5% CO2. After rehydration 250pl of the DMEM was carefully removed and 750pl 
of DMEM + 10%FCS was placed in the bottom of each well of the plate. Cells were 
harvested with trypsin 48 hrs post-transfection with siRNA oligos and resuspended in 
DMEM + 10%FCS. The number o f viable cells for each sample was counted using a 
Beckman Coulter Counter. An equal number of viable cells from each transfection 
condition were pelleted by centrifugation at lOOOg for 5 mins. The cell pellet was gently 
resuspended in DMEM +1%  FCS to a final concentration of 4 x lO'^  cells/ml. and 500pl 
of cell suspension (i.e. 2 x 10"^  cells) were added to the upper chamber of each Boyden 
chamber, another sample of cells were taken to analyse the efficiency of knockdown by 
westem blot.
The plates were incubated at 37^C, 5% CO2 for 24 hrs. After 24 hrs cells and the matrix 
in the upper chamber of the Boyden chamber were removed by gently cleaning the 
upper surface with a damp cotton bud. The inserts were processed and the number o f 
cells that had invaded were counted as for the Boyden chamber migration assays 
(2.7.3.5).
2.7.4 Lipid Extractions
1) All glassware (glass universals, specimen tubes, funnel, chromacol screw-top 
vial and Pasteur pipettes) was silanated prior to use. Glassware was soaked in a 
3% solution of dimethyldichlorosilane in HPLC grade toluene in a fume hood for
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1 hr, rinsed twice with methanol and twice with HPLC grade water and allowed 
to dry.
2) Two mixures of internal standards are prepared: one containing the Pis (IS) 
(DPPI(4)P, DPPI(4,5)P2 and DPPI(3,4,5)P3) at lOOpg/ml in 
chloroform:methanol:water (C:M:W) at 5:5:1 and the other containing other 
phospholipids (IS2) (DLPC, DLPA, DTPS, DLPG, DLPE and DPPI) at 
lOOpg/ml in C:M:W at 5:5:1
3) 200|il o f sample is added to 4ml of acidified C:M (2.5:1) in a glass universal.
4) The mixture is probe sonicated for 10 secs at power 22 and left at RT for 1 hr.
5) Samples are filtered through a 0.22pm membrane resistant to chloroform by 
vacuum filtration and collected in a specimen tube.
6) The sample is supplemented with 0.2 volumes of K4EDTA, transferred to a 
chromacol screw-top vial using a Pasteur pipette and spun at 800g for 15 mins at 
4 T .
7) The organic phase is collected, transferred to a fresh chromacol tube and dried at 
37 °C under nitrogen using a sample concentrator.
8) The lipid pellet is resuspended in 100 pi C:M:W (5:5:1) and transferred to a 
lOOpl silanised insert using a lOOpl gastight syringe. The insert is placed in an 
amber vial and the lipids dried under nitrogen.
9) 2pg of IS and 2pg of IS2 are added and dried under nitrogen.
10) Samples are stored art -80°C until analysed on an HPLC-tanderm mass 
spectrometer by members of the Biophysics laboratory at CR-UK.
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Chapter 3 
PKN1 and hyperosmotic stress 
3 Introduction
As was discussed in Chapter 1 the temporal and spatial control of kinase activity is 
vitally important for appropriate responses to be mounted to specific stimuli. PKN 1 has 
been demonstrated to have multiple roles in signal transduction (see 1.8.1) and so 
control over the localisation of PKN 1 activity is likely to be important.
An examination of PKN 1 localisation in response to various stimuli had previously 
uncovered a role for PKN 1 as a stress responsive kinase. It was demonstrated that in 
response to hyperosmotic stress ectopically expressed PKN 1 translocated in a reversible 
manner to punctate structures (Torbett et al., 2003). Initially it was thought likely that 
the structures observed in response to hyperosmotic conditions were membrane bound 
vesicles particularly as it has been shown previously that Rho B can target PKN 1 to 
endosomes (Mellor et al., 1998) and regulate traffic of the epidermal growth factor 
receptor (Gampel et al., 1999). However no evidence of the hyperosmotic induced 
structures co-staining with common endosomal markers or markers of other vesicular 
structures such as the Rab proteins was found. The nature of the structures that PKN I is 
targeted to remains unknown but it is known that the recruitment o f PKN I is dependent 
on Racl. Interestingly one of the consequences of hyperosmotic stress is a remodelling 
o f the actin cytoskeleton (see 1.8.1) and Racl is an important regulator of the 
cytoskeleton (see 1.6.1). It is therefore possible that PKNl is involved in this 
reorganisation of the cytoskeleton.
This chapter seeks to address how PKN I is targeted to these structures in response to 
hyperosmotic stress in an attempt to further our understanding o f the role o f PKN I in 
this hyperosmotic stress response
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3.1 PKNl translocation is triggered by 
mechanicai stress
The translocation o f PKN 1 was described previously to occur in response to 
hyperosmotic stress caused by exposure to 0.4M sucrose. Sucrose is membrane 
impermeant and so causes an external increase in osmolarity resulting in an efflux of 
water from the cell. This results in an increase in intracellular ionic strength and causes 
cells to shrink so the hyperosmotic stress is accompanied by a mechanical stress 
component. Therefore to address the question of whether the PKN 1 translocation is 
induced by intracellular hyperosmolarity or mechanical stress the effect of sucrose vs 
urea induced hyperosmotic stress was examined. Urea is membrane permeant and so 
hyperosmotic stress induced by it results in both an internal and external increase in 
osmolarity and no overall efflux of water from the cell and hence no mechanical stress. 
GFP-PKNl was expressed in NIH3T3 cells and the effect of an increase in osmolarity to 
740 mOsmol/Kg for 30 minutes was examined. As previously observed exposure to a 
hyperosmotic stress caused by sucrose resulted in an accumulation o f GFP-PKN 1 in 
large punctate structures. However a similar increase in osmolarity caused by exposure 
to urea did not result in any gross change in GFP-PKN 1 localisation (Figure 3:1).
This suggests that the PKN 1 translocation is induced by the mechanical stress of an 
increase in osmolarity caused by sucrose rather than the concurrent increase in 
intracellular ion concentration.
GFP-PKN 1 overexpression is also seen to affect the actin cytoskeleton under 
hyperosmotic conditions. In response to hyperosmolarity caused by both sucrose and 
urea actin is redistributed from filaments to a cortical ring around the edge of the cell. 
However in GFP-PKN 1 expressing cells in response sucrose treatment actin colocalises 
with PKN 1 in punctate structures. In response to urea treatment however GFP-PKN I 
expression instead stabilises actin in filaments.
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Basal conditions 0.4M sucrose 0.5M urea
GFP-PKNl FL
Phalloidin
Tubulin
Figure 3:1 GFP-PKNl translocates in response to mechanical stress and affects the 
rearrangement of the actin cytoskeleton under conditions of hyperosmolarity.
NIH3T3 cells were transiently transfected with GFP-PKNl and either untreated (basal 
conditions) or subjected to 30 minutes of hyperosmolarity by treatment with either 0.4M 
sucrose or 0.5M urea. After fixation actin was visualised using phalloidin-Alexa546 and 
stained for tubulin expression. All images are a single l.OpM ‘Z ’ section and are 
representative o f at least 30 fields from three independent experiments, the scale bar is 
equivalent to lOpM.
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3.2 Defining the hyperosmotic response region of 
PKN1
It was found previously that both PKNl and PKN2 show similar changes in localisation 
in réponse to a transient increase in osmolarity to 740 mOsmol/Kg (Dr Torbett, personal 
communication). It was known that the kinase domain o f PKN 1 controlled this 
localisation since the kinase domain alone displays the same response as the full-length 
protein. This behaviour is specific to the PKN isoforms compared to other closely 
related kinase domains such as those of PKC<!^  and PKCe. This is intriguing as it might 
have been predicted that the regulatory domain of the PKN isoforms would be 
responsible for the dynamic regulation of their localisation since this is where the PKN 
family differ most significantly from other PKC family members. To understand which 
region of the kinase domain conferred the PKN specific behaviour, the localisation of 
PKN1/PKC(!^ kinase domain chimeras were examined. The PKC(^ kinase domain was 
chosen since it has a high degree of homology to those of the PKN isoforms and in 
particular they all contain acidic residues in the hydrophobic “phosphorylation” site. 
Boundaries of the chimeras were decided based on molecular modelling and sequence 
homology of the two kinase domains to minimise the chance of the chimeric proteins 
being misfolded (Figure 3:2). All the chimeras were N-terminally GFP tagged and 
transiently over-expressed in N1H3T3 cells. Their localisation in response to 30 minutes 
o f hyperosmolarity caused by 0.4M sucrose was examined and compared to the PKNl 
and PKC(!^  kinase domains.
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Figure 3:2 Design of PKNl/PKCzeta chimeras.
Chimera boundaries were designed based on sequence comparisons of the PKN 1 and 
PKC(!^  kinase domains to limit the possibility of the chimeras being misfolded. They 
were cloned into pEGFP-Cl to enable expression in frame with a N-terminal GFP tag 
(see 2.6.1.8 for cloning strategy).
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3.2.1 The osmotic response element is within the lower 
lobe of the PKNl kinase domain
The initial chimeras were designed to establish which of the three main structural 
domains of the kinase domain were required for the punctate localisation. The PKN 1 
and PKC(!^  kinase domains are predicted to have a classical bilobal structure with an 
upper lobe, lower lobe and a short C-terminal region. Figure 3:3 shows representative 
pictures of the localisation of each of these chimeras and of the wild-type kinase 
domains. As expected the GFP-PKN 1 CD translocated to punctate structures in response 
to hyperosmotic stress whereas the GFP-PKC(!^ CD did not show any change in 
localisation. Chimeras 1 and 3 both showed a similar re-distribution in response to 
hyperosmolarity as the PKN 1 kinase domain. Although some cells displayed some 
punctate staining under basal conditions this was markedly increased in response to 
hyperosmolarity as is observed for the PKN 1 kinase domain. Chimera 2 however had a 
much more even cytoplasmic distribution, like that of the PKC(!^  kinase domain, under 
basal conditions. There was no change in the localisation of chimera 2 in response to 
hyperosmolarity. Chimeras 1 and 3 both contained the PKN 1 lower lobe region wheras 
chimera 2 contained the PKC<  ^sequence at this point (see Figure 3:2). From this it was 
concluded that the lower lobe of the PKN 1 kinase domain is required for recruitment of 
the protein to the hyperosmotically induced punctate structures.
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GFP-PKNl CD
GFP-Chimera 1
GFP-Chimera 2
GFP-Chimera 3
Basal conditions Hyperosmotic conditions
GFP-PKCzeta CD
Figure 3:3 The lower lobe of the PKNl kinase domain is required for translocation 
of the protein in response to hyperosmotic stress.
NIH3T3 cells were transiently transfected with GFP-PKNl CD, GFP-PKCzeta CD or 
GFP-Chimera 1/2/3 and either untreated (basal conditions) or subjected to 30 minutes of 
hyperosmolarity by treatment with 0.4M sucrose (hyperosmotic conditions). The scale 
bar is equivalent to lOpM. All images are a single l.OpM ‘Z ’ section and are
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representative of at least 30 fields firom three independent experiments, the scale bar is 
equivalent to lOpM.
3.2.2 A 49 amino acid domain is necessary for 
recruitment to punctate structures
To further narrow down the osmotic responsive region of PKN 1 another series of 
chimeras were designed and their localisation in response to hyperosmotic stress 
examined. All of these new chimeras behaved in the same way both under basal and 
hyperosmotic conditions as the PKN 1 kinase domain (see
Figure 3:4). That is they all displayed some punctate staining under basal conditions that 
was increased in response to hyperosmolarity. This suggests that the initial 49 amino 
acids of the lower lobe region are necessary for the PKN 1 -like localisation of the 
chimeric proteins.
3.2.3The 49 amino acid domain is sufficient for 
iocaiisation
To determine whether the 49 amino acids were sufficient for localisation to these 
distinct PKNl structures these 49 amino acids were expressed with an N-terminal GFP 
tag and the localisation of this peptide under basal and hyperosmotic conditions 
examined. Under basal conditions this peptide was localised primarily in punctate 
structures and no change in the number or size of vesicles was seen in response to 
hyperosmolarity. To confirm that the localisation of the GFP-49aa peptide was the same 
as that of the full-length protein, DsRed-PKN 1 FL was co-expressed with the GFP-49aa 
construct in NIH3T3 cells. Consistent with the behaviour of GFP-PKNl FL the DsRed- 
PKN 1 FL had a diffuse cytoplasmic distribution under basal conditions but translocated 
to punctate structures in response to hyperosmolarity. Under hyperosmotic conditions in 
cells co-expressing both DsRed-PKN 1 FL and the GFP-49aa both proteins are seen to
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localise to punctate structures and a large number of these structures are positive for 
both proteins (Figure 3:5).
Basal conditions Hyperosmotic conditions
GFP-Chimera 2.1
GFP-Chimera 2.2
GFP-Chimera 2.3
ii#
Figure 3:4 The initial 49 amino acids of the lower lobe are required for 
hyperosmotic induced recruitment to punctate structures.
N1H3T3 cells were transiently transfected with GFP-Chimera 2.1, 2.2 or 2.3 and either 
untreated (basal conditions) or subjected to 30 minutes of hyperosmolarity by treatment 
with 0.4M sucrose (hyperosmotic conditions). All images are a single l.OpM ‘Z ’ section 
and are representative of at least 30 fields from three independent experiments, the scale 
bar is equivalent to lOpM.
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GFP-49aa DsRed-PKN 1 MERGE
Figure 3:5 The 49 amino acid domain is sufficient for recruitment to PKNl 
hyperosmotic induced structures.
NIH3T3 cells were transiently co-transfected with DsRed-PKN 1 and GFP-49aa and 
subjected to 30 minutes of hyperosmolarity by treatment with 0.4M sucrose. All images 
are a single l.OpM ‘Z ’ section and are representative o f at least 30 fields from three 
independent experiments, the scale bar is equivalent to 1 OpM.
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3.2.4 The 49 amino acid domain is found on the surface 
of the protein.
The 49 amino acid domain found to be responsible for PKN 1 recruitment to punctate 
structures in response to hyperosmolarity consists of residues 699-747 found at the start 
of the lower lobe of the kinase domain. It would be informative to know whether the 
domain is exposed or buried within the protein structure and what its tertiary structure 
is. Although the structure of the PKN 1 kinase domain has not been solved it is possible 
to make some predictions based on the solved structure of the PKC0 kinase domain (Xu 
et ah, 2004) since the primary sequences of the PKN 1 and PKCO kinase domains are 
highly similar. ClustalX was used to align the sequences of the PKN 1, PKCÇ and PKCO 
kinase domains (see Figure 3:6). This alignment was then used to highlight in the PKCO 
structure the location of the PKN 1 domain responsible for the recruitment of PKN 1 to 
punctate structures under conditions of hyperosmolarity (see Figure 3:7). It can be seen 
from this modelling that the novel 49 amino acid domain is found on the surface of the 
protein and has a helix-loop-helix structure. This suggests that this domain would be 
accessible to interact with lipid or protein partners that could recruit the protein to a 
distinct cellular location in response to hyperosmotic stress.
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Figure 3:6 ClustalX alignment of PKNl PKCÇ and PKC0 kinase domains.
The 49 amino acid domain identified to be sufficient for recruitment to punctate structures is shown bounded by the red box.
Figure 3:7 Location and structure of the 49 amino acid domain.
The programme ClustalX was used to produce an alignment between the sequences of 
the kinase domains o f PKNl and PKC0. This alignment allowed the relevant 49 amino 
acids in the PKC0 structure to be highlighted in yellow. Critical catlytic residues are 
also highlighted to demonstrate the position of the active site, VAIK-green, DFG-dark 
blue, HRD-turquoise (see Table 2 in Section 1.3.1).
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3.3 Cellular distribution of PKN1
Having identified a discrete sequence of PKNl that is responsible for targeting the 
protein to the punctate structures the next aim was to identify the nature of the 
interaction that occurs to target PKN1 to the punctate structures. Purifying the structures 
and carrying out a proteome and/or lipidome of the complex would result in a greater 
understanding of the hyperosmotic response signalling pathway PKN 1 lies on and guide 
further studies on the function of these novel punctate structures. To purify the 
structures a classical sucrose gradient method was followed designed for the purification 
of small membrane structures such as endosomes to attempt to obtain a fraction enriched 
in the hyperosmotically induced structures. In this method protein complexes and 
membrane-bound structures such as endosomes are separated from cytoplasmic proteins 
based on their density such that free cytoplasmic proteins are found in low density 
fractions and structures such as endosomes are found in higher density fractions. 
NIH3T3 cells were used to examine the distribution of endogenous PKNl, GFP-49aa 
(which is constituitively localised to punctate structures) or GFP-Chimera 2 (which is 
not localised to hyperosmotically induced structures) under either basal or hyperosmotic 
conditions (see Figure 3:8). From these results it can be seen that endogenous PKNl is 
found primarily in the lower density fractions (2 and 3) both under basal and 
hyperosmotic conditions with a slight enrichment in higher density fractions under 
hyperosmotic conditions. The distribution of GFP-Chimera 2 is similar to that of the 
endogenous PKNl with it being found predominantly in the lower density fractions. 
Most interestingly although the soluble GFP-49aa is distributed throughout the fractions 
the majority of this protein is found within the pellet material that is cleared from the 
cell lysate prior to the lysate being loaded onto the sucrose gradient. Since the GFP-49aa 
is known be located in the punctate structures (see Figure 3:5) this observation suggests 
that the PKN 1 structures seen to accumulate after hyperosmotic shock are not free in the 
cytoplasm are therefore not loaded onto the sucrose gradient. The pellet from the lysate 
clearing centrifugation step contains large organelles such as the nucleus and cellular 
components linked to the cytoskeleton. It is possible that the GFP-49aa material found 
in the pellet is nuclear material since some nuclear staining is observed by 
immunofluorescence. However the GFP-Chimera 2 shows a similar degree of nuclear
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localisation as the GFP-49aa but a much lower proportion o f the GFP-Chimera 2 is 
found within the pellet material. This suggests that the punctate structures we were 
trying to purify by this method are found within the pellet material due to being linked 
to the cytoskeleton. This is supported by the previous observation that actin colocalises 
with GFP-PKNl in the punctate structures in response to hyperosmolarity (see Figure 
3:1).
0.3M
sucrose
1.2M
sucrose
Fraction: 1 2 3 4  5 6 7 8 9 1 0 1 1 1 2  Pellet
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PKNl+0S
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C him era 2-OS 35kDa
+0S GFP-49aa
Figure 3:8 Distribution of PKNl across sucrose gradient fractions.
NIFI3T3 cells were transiently tranfected with GFP-Chimera 2 or GFP-49aa; 48 hours 
post-transfection cells were placed in iso-osmotic or hyperosmotic media for 30 
minutes. After 30 minutes treatment cell lysates were prepared by breaking open the 
cells in a cell cracker. A low speed centrifugation was performed to clear the lysate of 
cellular debris such as unbroken cells, nuclei and the cytoskeleton and the supematents 
from this spin step were loaded onto a continuous sucrose gradient (0.3M to 1.2M 
sucrose). After overnight centifligation 1 ml fractions were collected and samples of 
each were run on an SDS-PAGE gel and western blots were carried out to look at the 
distribution o f the transfected GFP-49aa, GFP-Chimera 2 and endogenous PKN 1.
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To investigate further the cellular localisation of the hyperosmotic induced PKNl 
structures cell fractionation procedures were carried out. These involved looking at the 
solubility of PKN 1 in various detergents, the results of such an experiment are shown in 
Figure 3:9. NIH3T3 cells expressing either GFP-PKNl, GFP-PKNl CD or GFP-49aa 
were harvested into a buffer containing 0.05% digitonin to allow cytoplasmic proteins to 
leak out of the cells and be recovered by centrifugation. The pellet from the 
centrifugation step was then resuspended in a buffer containing 0.5% Triton-X-100 to 
solubilise membranes and allow integral membrane proteins and proteins contained 
within membrane bound structures to be recovered by a further centrifugation step. 
From these experiments it can be seen that endogenous PKNl is found in the initial 
digitonin extracted sample suggesting that it is localised in the cytoplasm under both 
basal and hyperosmotic conditions. GFP-PKNl FL is found both in the digitonin 
extractable fraction and in the Triton-X-100 insoluble fraction where it is slightly 
enriched in response to hyperosmolarity suggesting that the punctate structures are 
indeed insoluble. The greater proportion of both GFP-PKNl CD and GFP-49aa is found 
within the insoluble fraction both under basal and hyperosmotic conditions.
The experiments presented here together suggest that the punctate structures are 
detergent insoluble and are therefore not particularly amenable to purification to enable 
identification of interacting partners.
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Figure 3:9 Solubility of endogenous and overexpressed PKNl
NIH3T3 cells were harvested into lysis buffer containing 0,05% digitonin 48 hours post­
transfection and incubated for 30 minutes at 4°C. Samples were centrifuged at 
MOOOrpm for 15 minutes and LOS sample buffer added to the supematents (Digi. 
samples). The pellets from the centrifugation step were resuspended in lysis buffer 
containing 0.5% Triton-X-100 and incubated for 30 minutes at 4°C prior to a second 
MOOOrpm centrifugation being performed. LDS sample buffer was added to the 
supematents (T-X-100 samples) and pellets (Ins. samples) from this second 
centrifugation. All samples were mn on SDS-PAGE gels and distribution o f PKN 1 and 
GFP tagged proteins analysed by westem blot. The images shown are representative of 
the results obtained from two independent experiments.
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3.4 Discussion
The results described in this chapter further our understanding of PKN 1 localisation by 
defining a domain that is both necessary and sufficient for targeting PKN 1 to a distinct 
cellular location in response to mechanical stress caused by hyperosmolarity. It was 
known previously that PKNl recruitment to punctate structures under hyperosmotic 
conditions is mediated through the kinase domain. This work has further defined the 
domain required for the translocation of PKN 1 to a 49 amino acid stretch found at the 
start of the lower lobe of the kinase domain. This region displays no similarity to any 
other known interaction domain and so it remains unclear whether this novel domain 
interacts with a protein or lipid partner to mediate translocation of PKN 1 in response to 
hyperosmolarity. The constitutive localisation of the tagged 49 amino acid peptide to 
punctate structures is not unexpected. The localisation of the full length protein was 
shown previously to be dependent on Rac activation (Torbett et al., 2003). It has been 
suggested that the interaction of Rho GTPases with the amino terminal HRl motif of the 
regulatory region disrupts an autoinhibitory intramolecular interaction and hence causes 
a change in conformation that allows PKNl to become activated (Kitagawa et al., 1996). 
It is therefore logical to propose that Rac binding to the full-length protein in response to 
hyperosmolarity results in an open conformation of PKN I which exposes the 49 amino 
acids at the entrance to the substrate binding pocket. With this domain exposed and 
available to bind the relevant protein or lipid partner PKN I is recruited to the punctate 
structures. However if the domain is expressed alone then it is permanently recruited to 
the structures by its interaction partner. Unfortunately attempts to identify proteins that 
interact with this 49 amino acid domain were hampered by the detergent insolubility of 
overexpressed PKN I , prehaps due to an association with the cytoskeleton. In addition to 
the work shown here further evidence that the PKN I complex is insoluble comes from 
observations made by Dr Adele Casimassima, a post doc in the lab. Dr Casimassima has 
been working on the PKN 1 osmotic response pathway and attempting to reconstitute the 
signalling complex by co-expressing PKNl, JIP and MKK4 which are all seen by 
immunofluorescence to colocalise in the vesicular structures after hyperosmotic shock. 
This work has involved overexpressing these proteins in cells and looking at interactions 
between them by immunoprécipitation (IP). Routinely, cell lysates are cleared by
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carrying out a low speed centrifugation prior to IP and the IP carried out on the 
supematent of this centrifugation. In cells subjected to hyperosmotic shock the over­
expressed proteins are unable to be immunoprecipitated from the cleared cell lysate. 
Instead they appear in the pellet from the low speed centrifugation suggesting that the 
proteins become insoluble due to the hyperosmotic shock.
This chapter also looked at whether PKN 1 is recruited to the structures in response to 
the increase in intracellular ionic strength or by the mechanical stress resulting from 
hyperosmolarity caused by sucrose exposure. Using urea to cause hyperosmolarity 
allowed us to address this question and it was found that the same increase in osmolarity 
did not elicit the same PKN 1 translocation. This result implies that the PKN 1 
translocation is stimulated by the mechanical stress that is caused due to cell shrinkage 
specifically brought about by cell membrane impermeant solutes such as sucrose. Under 
hyperosmotic conditions PKN 1 was seen to colocalise with actin and the level of 
disruption of the actin cytoskeleton in response to sucrose treatment was greater in cells 
overexpressing GFP-PKN1. These results together provide some evidence o f PKN 1 
involvement in the rearrangement of the cytoskeleton and mechanotransduction of 
signals in response to hyperosmolarity. Consistent with this idea it has been shown by 
Dr adele casamassima (a post-doc in the lab), that upon hyperosmotic shock proteins of 
the INK signalling pathway are co-recruited into this compartment. These include JNK 
interacting protein (JIPI) and MKK4. Additionally it has been observed that in PKNl 
KO MEFs the activation of JNK in response to hyperosmotic shock is impaired. These 
observations raise the possibility that the PKN I structures induced by hyperosmotic 
conditions form a signalling complex somehow linked to the cytoskeleton that is 
important for cellular changes in response to hyperosmolarity.
The work in this chapter relied on the overexpression of PKN 1 to enable a chimera 
based approach to define the hyperosmotic response region. However it was also found 
that overexpressing PKN 1 affects the cytoskeletal rearrangements in response to 
hyperosmolarity. This observation coupled with the numerous reports o f PKN 1 
interacting with cytoskeletal components led to an interest in examining the role of 
endogenous PKN 1 in control of the cytoskeleton. An important physiological role for
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the cytoskeleton is in controlling cell movement and pathologically cell movement is 
extremely important in the metastasis of cancer cells. The next chapter will therefore 
investigate if PKNl is involved in controlling the migration or invasion of cancer cells.
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Chapter 4 
PKN1 in migration and invasion 
4 Introduction
As was discussed in the introductory chapter cell motility is a multi-step process and 
much work is going into dissecting the roles different proteins play in the signalling 
pathways involved. One of the essential processes of cell motility is remodelling of the 
cytoskeleton to produce the force necessary to drive cells forward. Major regulators of 
the cytoskeleton dynamics seen in migrating and invading cells are the Rho GTPases 
(for review see (Raftopoulou and Hall, 2004)). Since the PKNs are downstream 
effectors of these molecular switches it is of course interesting to speculate on a role for 
them in controlling cell motility. Additionally the PKNs have, as mentioned before, 
been reported to have numerous interactions with cytoskeletal components and in the 
previous chapter overexpression of PKN 1 was shown to affect the rearrangement of the 
actin cytoskeleton. In searching for a role for endogenous PKN 1 it therefore seemed 
appropriate to investigate motility of transformed cells.
Interestingly PKN isoforms have already been shown to have a function in prostate 
cancer. PKN3 has been found to be an effector of the PI3K pathway in PC3 cells (a 
prostate cancer cell line) and is required to mediate the invasive cell growth resulting 
from activation of this pathway (Leenders et al., 2004). PKN 1 has been shown to 
activate the androgen receptor, a ligand-activated transcription factor that is thought to 
play an important role in the development of prostate cancer (Metzger et al., 2003). The 
study by Leenders et al is particularly interesting since it implicates PKN3 in control of 
metastasis of PC3 cells in vivo, suggesting that PKN3 regulates cell adhesion or 
motility.
The results in this chapter describe use of siRNA mediated depletion of the PKN 
isoforms and inhibition of PKN activity to investigate if the PKNs have a role to play in 
regulating the migration and invasion of transformed breast cells.
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4.1 PKN isoform expression varies between 
cancer cell lines
To investigate PKN involvement in transformed cell motility it was decided to use 
cultured transformed cells and in vitro motility assays. Transformed cell lines generated 
from patient tumour samples provide a valuable way of investigating the signalling 
pathways involved in many different aspects of cancer cell biology. To decide which 
transformed cell models to use the levels of PKN expression in seventeen different cell 
lines derived from six different tumour types was examined.
The expression levels of the three PKN isoforms in these breast, lung, prostate, colon, 
liver and kidney, transformed cells are shown in Figure 4:1. All but one of the cells lines 
expressed at least one PKN isoform, the exception being the colon HT29 cell line. Most 
of the cell lines tested expressed all three isoforms to a greater or lesser extent and it 
does not appear that any one isoform is more likely than the others to be expressed. 
However the absolute expression levels of each of the three isoforms is not known since 
the efficiency of detection of the three antibodies may be very different. Comparisons of 
single isoform expression levels between the different cell lines can be made though. 
PKN2 expression is lower in the colon, liver and kidney cell lines than in the breast, 
lung and prostate cell lines. There is no obvious correlation between PKN 1 or PKN3 
expression levels and cell type.
As discussed previously PKN3 has been implicated in the motility of transformed 
prostate PC3 cells (Leenders et al., 2004). Prostate cells share similarities to breast cells 
in that they are both constituents of hormone responsive organs and tumours arising 
from these tissues are often regulated by hormones (Lange et al., 2007). Therefore it was 
decided to investigate PKN function in the motility o f breast cells. Two of the 
transformed breast cell lines, the MDAMB-231 and MDAMB-468, display high levels 
of expression of all three PKN isoforms. However the other transformed breast cells, the 
MCF7s, predominantly express PKNl. Therefore to examine the role of PKNl in the 
motility of transformed cells the MCF cell line was chosen for study and to assess the 
contribution of all three PKN isoforms to transformed cell motility the MDAMB-468 
cells were chosen.
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Figure 4:1 PKN expression levels in cancer cell lines.
Cell lysates were prepared from each cell line and 30pg total protein was loaded for 
each cell line. PKN expression levels were detected with the relevant antibodies. 
Tubulin levels were detected to demonstrate equal loading of each lysate.
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4.2 PKN involvement in migration is cell type 
dependent.
To determine if the PKNs play a role in the motility of two transformed breast cell lines 
scratch wound assays were employed. This assay measures the speed at which cells 
migrate to close a gap created in an otherwise confluent layer of cells. By comparing the 
speed at which the gap is closed in control cells versus treated cells it can be seen if the 
condition tested affects migration. To examine if PKNl has a role in regulating 
migration, MCF7 cells were either mock transfected, control transfected with an oligo 
targeting luciferase (LUC control) or depleted o f PKNl by transfection of one of two 
oligos specifically designed to only target PKN 1. 72 hours post transfection the 
confluent layers of cells were wounded and an area of each wound was filmed over 24 
hours to follow the closure of the wound (representative images shown in Figure 4:2c). 
The speed of closure was compared in each case to the LUC control wounds to give the 
relative speed of migration Figure 4:2a shows the average results from three such 
experiments. It can be seen that the control LUC transfection had no effect on the speed 
of migration compared to the MOCK transfection control. The two oligos targeted 
against PKNl (lA  and IB) both deplete the levels of PKNl by about 70% compared to 
the control transfections (Figure 4:2b). Flowever despite achieving a good level of 
knockdown of PKN 1 no effect on migration is seen. Whilst the average speed of 
migration relative to the LUC control is decreased upon depletion of PKN 1 with both 
the lA  and IB oligos this decrease is not statistically significant due to variability in the 
assay. PKN 1 therefore was concluded not to play a rate limiting role in the migration of 
MCF7 cells in this system.
Unlike the MCF7 cells the MDAMB-468 cells express all three PKN isoforms (see 
Figure 4:1). Since both PKN2 and PKN3 have been reported to play roles in control of 
cell motility it was decided to use siRNA to deplete all three isoforms to overcome 
possible problems of redundancy. Once again a scratch wound assay was used to assess 
the contribution of the PKN isoforms on migration of this cell line. As can be seen from 
Figure 4:3b the levels of PKNl and PKN2 were successfully depleted compared to the 
LUC control. Unfortunately despite previous successful detection of PKN3 levels using
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an in-house rabbit polyclonal antibody (see Figure 4:1) this antibody no longer enabled 
detection of a specific PKN3 protein band. A new batch of anti-sera was purified to 
attempt to overcome this problem but again no protein bands were detected at any 
antibody concentration or incubation conditions. However it is known that the siRNA 
oligo used to target PKN3 is capable of achieving knockdown as reported by Leenders 
et al who used a rabbit polyclonal antibody they had raised against PKN3 to check 
PKN3 knockdown in PC3 cells (Leenders et al., 2004). Additionally Dr Sylvie 
Lachmann in our lab showed that the PKN3 siRNA oligo was capable of depleting the 
levels of overexpressed GFP-PKN3 (see Figure 4:4). Therefore in the absence o f a 
stable in-house anti-sera or a good commercial antibody for PKN3 it was assumed that if 
depletion of PKNl and PKN2 was achieved then the transfection of the siRNA oligos 
was successful and hence PKN3 levels would also have been depleted albeit the extent 
could not be confirmed. The average results of four assays comparing the effect o f PKN 
isoform depletion on migration relative to a LUC control are shown in (Figure 4:3). 
Depletion of the PKN isoforms was seen to result in a statistically significant (30%) 
decrease in migration compared to the LUC control.
These results suggest that the PKNs contribute to cell migration in a cell type dependent 
manner since in MCF7 cells where PKN 1 is the predominant isoform knockdown of 
PKN 1 does not affect the speed of migration. However in MDAMB-468 cells that 
express all three PKN isoforms combined knockdown of the isoforms results in a 30% 
decrease in the speed of migration relative to the LUC control. However it can not be 
conclusively stated that the PKN isoforms contribute to cell migration in the MDAMB- 
468 cells since there is a possibility that the siRNA oligos are having off-target effects 
(Jackson and Linsley, 2004), this consideration and possible further validation 
experiments are discussed in more detail in chapter 6.
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Figure 4:2 PKNl depletion does not affect MCF7 cell migration.
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a) Confluent layers of MCF7 cells were scratched 72 hours after transfection with 
siRNA oligos. The wound areas were filmed for 24 hours and the speed o f closure 
calculated relative to the LUC controls, n=3 performed in triplicate and the error bars 
show the standard error. Bonferroni corrected Z tests were performed; n.s. indicates 
no significant change in speed of migration relative to control.
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Tubulin
b) Cells were harvested at the end of each experiment and PKN 1 and tubulin levels 
detected by westem blot. The blots shown are representative o f the levels o f PKN 1 
knockdown achieved.
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c) Representative phase contrast images of MCF7 cells at the beginning and end of a 
scratch wound assay. Scale bars are equivalent to 300pm.
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Figure 4:3 PKNs contribute to MDAMB-468 cell migration.
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MDAMB-468 cells
LUC PKN 1 /2 /3
siRNA oligos transfected
a) Confluent layers of MDAMB-468 cells were scratched 72 hours after transfection 
with siRNA oligos. The wound areas were filmed for 24 hours and the speed of 
closure calculated relative to the LUC controls; n=4, performed in triplicate the error 
bars show the standard error. Bonferroni corrected Z tests were performed; n.s. 
indicates no significant change in speed of migration relative to control; ** represents
p<0.01.
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b) Cells were harvested at the end of each experiment and PKNl, PKN2 and tubulin 
levels detected by westem blot. The blots shown are representative of the levels of 
knockdown achieved.
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c) Representative phase contrast images of MDAMB-468 cells at the beginning and end 
of a scratch wound assay (see Appendix for movie files). Scale bars are equivalent to 
300pm.
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Figure 4:4 GFP-PKN3 is depleted by PKN3 siRNA oligo.
GFP-PKN3 was transiently expressed in 5637 cells (transformed bladder cell line) prior 
to transfection with siRNA oligos (either LUC control or targeted against PKN3). 72 
hours post-transfection with the siRNA oligos cells were harvested in sample buffer and 
westem blots performed to detect PKN3 and tubulin levels. This work was performed by 
Dr Sylvie Lachmann.
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4.3 The role of PKN In 2-D migration of MDAMB- 
468 cells is substrate specific.
Since the PKNs appear to contribute to the ability of MDAMB-468 cells to migrate it 
was decided to test whether the nature of the matrix-cell interaction had any effect on 
this involvement. Cells make contacts with the underlying substrate via cell surface 
receptors such as integrins (see 1.1.2). In order to assess whether the PKNs signalled 
downstream of specific integrins the effect of PKN depletion on migration on different 
substrates was examined. Cells were plated on laminin, fibronectin or collagen and 
scratch wound assays were performed. The results shown in Figure 4:5a are an average 
of three separate experiments where the effect of PKN depletion on speed of migration 
is shown relative to the LUC controls. The strongest effect of depletion of PKN 
isoforms on migration was seen when cells were plated on fibronectin. Under these 
conditions a 40% decrease in migration was observed. Pre-coating the plates with 
collagen resulted in a greater variability in migration between assays and makes the 30% 
decrease in migration observed not significant. Pre-coating the plates with laminin 
resulted in only a 20% decrease in migration due to PKN depletion. In Figure 4:3 it can 
be seen that cells migrating on untreated plates displayed a 30% decrease in migration 
upon PKN isoform depletion. However since these assays were carried out in the 
presence of 10% foetal calf serum and fibronectin is a common matrix constituent of 
serum it is likely that the same integrin receptors are engaged in this condition as when 
the plates were pre-coated with fibronectin.
These results suggest that the PKN contribution to cell migration is dependent on the 
extracellular ligands present and hence the cell surface receptors that are engaged.
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Figure 4:5 Substrate affects the contribution of PKN isoforms to migration of 
MDAMB-468 cells.
E ffect o f  PK N  knockdow n and substrate on m igration  in a scratch
w ound assay
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Substrate and transfection condition
a) Confluent layers of MDAMB-468 cells were scratched 72 hours after transfection 
with siRNA oligos. The wound areas were filmed for 24 hours and the speed of 
closure calculated relative to the LUC controls; n=2 performed in triplicate and the 
error bars show the standard error.
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b) Cells were harvested at the end o f each experiment and PKN 1, PKN2 and tubulin 
levels detected by westem blot LN-laminin, FN-fibronectin, CO-collagen. The blots 
shown are representative of the levels of PKN knockdown achieved.
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c) Representative phase contrast images of MDAMB-468 cells at the beginning and end 
of a scratch wound assays performed on different substrates (see Appendix for movie 
files). Scale bars are equivalent to 300pm.
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4.4 PKNs have isoform specific roles in the 2-D 
migration of MDAMB-468 cells.
Having shown that the PKN isoforms can play a role in the migration of MDAMB-468 
cells it was logical to next assess the relative contribution of each PKN isoform. In a 
scratch wound assay on uncoated plates knockdown of all three isoforms results in a 
30% decrease in migration compared to a LUC control. The same assay was employed 
to look at the effect of individual isoform and double isoform knockdown on migration 
compared to the effect achieved with triple knockdown (Figure 4:6). Consistent with the 
previous experiments, depletion of all three isoforms results in a 30% decrease in 
migration. Depletion of PKNl or PKN2 alone has a negative effect on migration 
whereas depletion of PKN3 has no significant effect on migration. PKNl apparently 
plays the greatest role in regulating migration since the largest reduction in migration 
relative to the control is seen when PKN 1 is depleted. However PKN 1 cannot 
compensate for PKN2 function since knockdown of PKN2 still results in a 25% 
reduction in migration.
The results of combining knockdown of two isoforms at the same time are particularly 
interesting. Knockdown of PKN 1 and PKN2 might have been expected to have an 
additive effect on migration compared to the 50% decrease seen with PKN 1 knockdown 
and the 25% seen with PKN2 knockdown. However this is not the case and only a 50% 
decrease in migration is seen. This suggests that PKNl and PKN2 have overlapping 
roles to play in the signalling pathways controlling the migration o f these cells. 
Interestingly if PKN3 is depleted alongside either PKNl or PKN2 then there is no 
longer any effect of depletion of PKNl or PKN2 on migration despite similar levels of 
knockdown of PKNl and PKN2 being achieved. This suggests that PKN3 knockdown 
overrides the negative effects of PKN 1/2 knockdown on migration. Consistent with 
PKN3 knockdown having a positive effect on migration is the observation that 
knockdown of all three isoforms together results in a 30% decrease in migration 
whereas knockdown of PKNl alone gives a 50% decrease in migration.
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These results suggest that although PKN 1 plays the greatest role of the three PKN 
isoforms in controlling migration all of the isoforms make a contribution to regulating 
migration in a scratch wound assay in MDAMB-468 cells.
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Figure 4:6 PKNl and FKN2 play a rôle in the migration of MDAMB-468 cells.
Contribution of PKN isoforms to migration of MDAMB-468 cells
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a) Confluent layers of MDAMB-468 cells were scratched 72 hours after transfection 
with siRNA oligos. The wound areas were filmed for 24 hours and the speed of 
closure calculated relative to the LUC controls; n=2 performed in triplicate and the 
error bars show the standard error.
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b) Cells were harvested at the end of each experiment and PKN 1, PKN2 and tubulin 
levels detected by westem blot.
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4.5 Substrate specific role for PKN isoforms in 
migration through a Transwell
It is becoming increasingly clear that the signalling pathways activated during cell 
motility depend on the type of motility being assessed (Friedl and Brocker, 2000). 
Whilst the scratch wound assays allow migration to be assessed in a collective 2- 
dimensional system, Boyden chambers, such as Coming Transwell inserts (Figure 4:7), 
allow single cell, chemotactic migration to be assessed.
a)
Polycarbonate membrane 
containing 8 pm pores
Lip o f Transwell allows insert 
to hang in well of a 24 well 
plate during experiment.
b)
2% FCS media 
10% FCS media
Trans well insert
Well of plate 
Cells
Figure 4:7 Schematic of Transwell insert system.
a) Diagram of a Transwell insert demonstrating location o f membrane containing 8pm 
pores.
b) The Trans well insert as used experimentally. Transwell insert is placed into a well of 
a 24 well plate, media added to the well and the insert and cells seeded onto the top 
of the Transwell insert membrane.
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Seeding cells directly onto the upper membrane of a Boyden chamber provides another 
assessment of the ability of cells to migrate albeit under different constraints to those 
imposed by the scratch wound assay previously used to investigate the PKNs 
contribution to cell migration. In the Boyden chamber migration assay cells must adhere 
to the upper surface of the membrane prior to migrating as single cells through the pores 
in the membrane towards a serum gradient.
To investigate if PKN isoforms play a role in the migration o f MDAMB-468 cells in this 
type of migration assay, cells were again depleted of all three PKN isoforms using 
siRNA. Since substrate had an effect on the role that PKN had to play in migration in 
scratch wound assays and to help aid migration through the membrane it was decided to 
pre-coat the bottom of the Trans well insert membranes with laminin, fibronectin or 
collagen. Similar to the scratch wound assay the effect of PKN isoform knockdown on 
migration was substrate dependent (Figure 4:8). The largest decrease in migration 
caused by PKN depletion was seen when cells were migrating onto a laminin coated 
surface, in this case a 40% decrease (p<0.01) in migration was observed. If the 
underside of the Transwell membrane had been pre-coated with collagen then the 
decrease in migration caused by PKN knockdown was approximately 30% (p<0.01). 
However unlike the scratch wound assay, (Figure 4:5), knockdown of PKN had no 
effect on migration if fibronectin was the substrate cells were migrating towards.
Despite the different substrates used on the underside of the membrane all cells should 
engage the same receptors initially to regulate their adhesion to the uncoated upper 
surface of the membrane. Therefore this suggests that the different requirements seen for 
the PKNs in migration are a result of differing roles for them in chemotactic motility.
It is particularly interesting that despite a requirement for the PKNs in migration on 
fibronectin there is no requirement for them in migration towards fibronectin. It was 
shown previously that in a scratch wound assay the PKN isoforms had different roles to 
play in controlling migration. The possibility is that the PKN isoforms also play 
different roles in migration in the Boyden chamber migration system.
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Effect of substrate and PKN isoform depletion on 
MDAMB-468 Transwell migration
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Figure 4:8 Effect of PKN depletion on migration through a Boyden chamber is 
substrate dependent.
72 hours post-transfection cells were harvested and counted. 5 x 10"^  cells were seeded 
into each Boyden chamber (which had been precoated with substrate on the underside 
of the membrane) and allowed to migrate for 5 hours. The number o f cells migrated 
through to the underside was counted and compared relative to the LUC control; n=3, 
performed in triplicate the error bars show the standard error. Bonferroni corrected Z 
tests were performed; n.s. indicates no significant change in migration relative to 
control; ** represents p<0.01.
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4.6 PKN isoforms show redundant function in 
Boyden chamber migration.
It was found in the scratch wound assay that PKN 1 was the predominant regulator of 
cell migration on fibronectin but that PKN2 also played a role. To examine the 
contribution of each PKN isoform in regulation of migration towards laminin the 
isoforms were depleted singly and in combination. Laminin was chosen as the substrate 
since the PKNs play the biggest role in migration towards laminin in the Trans well 
assay (Figure 4:8). Figure 4:9a shows the results of three experiments to assess the 
effect of PKN isoform depletion on migration of MDAMB-468 cells through a Boyden 
chamber towards laminin.
Despite achieving good knockdown of PKN 1 and PKN2 in each transfection condition 
(Figure 4:9b) a significant effect on migration is only seen when all three isoforms are 
targeted with siRNA (p<0.01). This shows that the presence of any of the three isoforms 
is sufficient to allow MDAMB-468 cells to migrate towards laminin i.e. the isoforms 
have redundant functions in this migration assay. This could be due either to 
upregulation of the signalling pathways which the remaining isoform(s) act on, or 
because they all lie on the same pathway. The finding that the PKN isoforms all have to 
be depleted in this assay for an effect on migration to be seen suggests that the oligos are 
not having an off-target effect on a key regulator o f cell migration.
The results from the Boyden chamber and scratch wound migration assays suggest that 
PKN function in cell motility is different depending on the environment and the nature 
of the cell migration that is being assessed. Another important mode of cell motility in 
cancer is invasion (see 1.7.2) and the contribution of the PKN isoforms to this mode of 
cell motility was investigated next.
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Figure 4:9 PKN isoforms display redundancy of function in migration towards 
laminin.
C ontribution  o f  PK N  isoform s to M D A M B -468 T ran sw ell
m igration
1.4
V
Isoforms depleted with siRNA
a) 72 hours post-transfection cells were harvested and counted. 5 x 1 O'* cells were 
seeded into each Boyden chamber (which had been precoated with substrate on the 
underside of the membrane) and allowed to migrate for 5 hours. The number o f cells 
migrated through to the underside was counted and compared relative to the LUC 
control; n=3, performed in triplicate the error bars show the standard error. 
Bonferroni corrected Z tests were performed; n.s. indicates no significant change in 
speed of migration relative to control; ** represents p<0.01.
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b) At the same time as cells were seeded into the Boyden chamber a sample o f each was 
taken and analysed by western blot for PKN expression levels to assess the 
effectiveness o f knockdown.
4.7 PKNs role in Invasion of MDAMB-468 cells.
By seeding cells into Boyden chambers that have been coated with a thin layer of 
extracellular matrix proteins the ability of cells to move through this matrix can be 
examined giving a measure of the invasive capability o f the cells. Growth factor reduced 
Matrigel is commonly used to assess invasion in this system and serves as a 
reconstituted basement membrane in vitro. According to the manufacturer its major 
constituent is laminin followed by collagen IV and other extracellular matrix 
components. Cells are seeded on top o f this layer and must move through the matrix to 
reach the pores in the membrane. Cells that have reached the underside of the membrane 
after a certain time period are then counted. This assay was used to investigate whether 
the PKNs contribute to the invasive phenotype of MDAMB-468 cells by examining the 
effect of depletion of the three PKN isoforms. Similarly to the migration assays 
comparison of the number of cells that invade after transfection with a Luciferase 
control siRNA oligo to the number of cells that invade after knockdown o f the PKN 
isoforms was used to investigate PKN involvement in cell invasion. Since in the Boyden 
chamber migration assay the PKN isoforms displayed redundant function it was decided
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to use a combined knockdown approach to examine if the PKNs contribute to invasion 
of MDAMB-468 cells.
The results from two experiments are shown in Figure 4:10. Relative to the LUC 
control, PKN depletion results in a 40% decrease in cell invasion. This result suggests 
that the PKN isoforms play a role in regulating the invasion of MDAMB-468 cells in 
vitro.
Figure 4:10 Effect of PKN knockdown on invasion of MDAMB-468 cells.
Effect of PKN depletion on invasion of MDAMB-468 cells
1.2
1
0.8
0.6
0.4
0.2
0
LUC PKN 1 /2 /3
Transfection condition
a) 72 hours post-transfection cells were harvested and counted. 5x10^  cells were 
seeded into each Boyden invasion chamber and allowed to invade for 48 hours. The 
number of cells on the underside of the membrane after this time was counted and 
compared relative to the LUC control, experiments performed in quadruplicate, n=2, 
the error bars display the standard error.
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b) At the same time as cells were seeded into the Boyden chamber a sample o f each was 
taken and analysed by western blot for PKN expression levels to assess the 
effectiveness o f knockdown
4.8 Inhibition of PKN activity prevents MDAMB- 
468 cell migration.
It has been shown that the PKNs may play a role in the migration and invasion of 
MDAMB-468 cells. However using an siRNA approach only gives us information on 
whether PKN presence is required and not whether PKN activity is necessary for 
migration. Ultimately the aim of understanding the signalling pathways involved in 
regulating cancer cell migration is to enable therapeutics to be developed to suppress 
metastatic behaviour o f tumour cells. Kinases are popular drug targets since it is 
comparatively easy to develop compounds to inhibit their activity due to the presence o f 
a defined catalytic pocket that can be targeted with ATP competitive compounds 
(Fabbro et al., 2002). In collaboration with Cancer Research Technology a library screen 
of small molecular weight compounds was undertaken to find novel PKN inhibitors.
This resulted in three related hits; one related compound that did not inhibit PKN 1 or 
PKN2 was chosen as a control. This collaboration is still ongoing and due to patenting 
restrictions the structures of these compounds can not be disclosed. The compounds will 
be referred to as A4 (the control), A5, A6 and A7. The IC50 values for PKN 1 of these
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compounds are; A4 >100pM, A5-7pM , A6-16.5pM and A7-3.5pM. The compounds 
A5, A6 and A7 are known to also inhibit PKN2 and PKN3 but the cell permeability o f 
the compounds is not known. A4 and A5 are structurally very highly related compounds 
whereas A6 and A7 are more diverse. To test the effect of inhibiting PKN activity on 
migration of MDAMB-468 cells, scratch wound assays were performed blind ^inhibitor. 
This assay was chosen for the ease of screening and to allow any effects o f the 
compounds on cell viability to be observed.
All three active compounds significantly decreased migration (p<0.01) by at least 55% 
when used at 30pM concentration whereas the inactive control A4 compound had no 
significant effect on migration decreasing migration by only 15% when compared to 
DMSO alone (Figure 4:11). A7 was observed to be mildly toxic to the cells over the 
time course of the assay but none of the other compounds were toxic to the cells, as 
judged by the extent of cell detachment from the substrate, at 30pM (see Appendix for 
movie files). These results suggest that the catalytic activity of the PKNs is required for 
MDAMB-468 cell migration although it is possible that kinases other than the PKNs 
that also contribute to cell migration are also inhibited by these compounds.
108
Figure 4:11 Inhibiting PKN activity decreases migration of MDAMB-468 ceils.
Effect of inhibiting PKN activity on MDAMB-468 cell
migration
1.2
DMSO A4 A5
30^M Compound
A6 A7
a) Confluent layers of MDAMB-468 cells were pre-treated with 30pM of the relevant 
compound for 1 hour prior to wounding. Migration into the wound area in the 
presence of 30pM compound was filmed over a period o f 24 hours and the time 
taken to close the wound compared to a DMSO control. The average speed of wound 
closure standardised to the DMSO control is shown and the error bars display the 
standard error; n=3 performed in triplicate; a Bonferroni corrected Z test was 
performed, n.s shows that no significant change in speed was observed, ** shows
p<0.01.
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b) Representative phase contrast images of MDAMB-468 cells at the beginning and end 
o f a scratch wound assays performed in the presence of CRT compounds or DMSO 
as a vehicle control (see Appendix for movie files). Scale bars are equivalent to 
300pm.
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4.9 PKN depletion does not affect the
cytoskeleton of spreading MDAMB-468 ceiis.
The results described in this chapter have indicated substrate and motility specific 
requirements for the PKNs. In Chapter 3 it was shown that overexpression of GFP- 
PKN1 affects cytoskeleton rearrangements under hyperosmotic conditions. Since cell 
motility involves dynamic regulation of the cytoskeleton it is possible that the PKNs 
play a role in these cytoskeleton rearrangements.
To investigate this possibility it was decided to look at the effect of PKN depletion on 
the actin and microtubule cytoskeleton. Cells were harvested 72 hours post transfection, 
seeded onto fibronectin coated glass coverslips and fixed at various time points to 
enable the cytoskeleton to be clearly visualised under dynamic conditions. Figure 4:12 
shows representative confocal images of MDAMB-468 cells that have either been 
transfected with the Luc control siRNA oligo or oligos against the three PKN isoforms. 
Several timepoints after seeding of the cells are shown to allow the changes in the 
cytoskeleton to be observed as the cells adhere and spread. The pictures show that whilst 
both the actin and tubulin networks both undergo changes over a 32 hour period there is 
no obvious difference in either network between control and PKN depleted cells. These 
results suggest that the PKN isoforms do not play a role in cytoskeleton remodelling 
under these conditions.
Figure 4:12 PKN depletion does not affect the cytoskeleton of spreading cells.
Following two pages: MDAMB-468 cells were either control transfected (LUC) or 
transfected with siRNA oligos against PKNl, PKN2 and PKN3 (PKN 1/2/3). 72 hours 
post-transfection cells were harvested and seeded onto fibronectin coated glass 
coverslips. Cells were allowed to adhere for the indicated times and then fixed. The 
actin and microtubule cytoskeleton was visualised by staining with phalloidin and anti­
tubulin antibody. The confocal images are a 1pm ‘Z ’ optical sections and are 
representative of three independent experiments. The scale bar is equivalent to 10pm.
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4.10 Discussion
This chapter set out to look at whether PKN 1 plays a role in transformed cell motility 
and the results described suggest that under certain circumstances PKN 1 contributes to 
the regulation of cell migration. However the results also suggest that PKN 1 is not a 
universal regulator of cell motility and indeed under some conditions has overlapping 
function with the two other PKN isoforms. Whilst the PKNs were found to be expressed 
across a spectrum of transformed cells it was decided to focus on investigating the role 
of the PKNs in the motility of transformed cells derived from tumours of the breast.
Since the interest of this thesis is primarily the PKNl isoform the MCF7 cell line was 
one of the transformed breast cell lines chosen to study since PKN 1 is the predominant 
isoform expressed in this cell line. Use of siRNA technology suggested that PKNl does 
not play a role in MCF7 cell migration. However results from the MDAMB-468 cell 
line show that the substrate cells are plated on affects whether the PKN isoforms control 
migration. This supports the idea that cell migration is regulated through different 
signalling pathways depending on which cell surface receptors are engaged. For 
example it has been shown that fibronectin binding pi integrins promote random 
migration through extension of multiple thin protrusions whereas in the same cell 
background fibronectin binding p3 integrins promote persistent migration through the 
formation of a single broad lamellipod (Danen et al., 2005). It is therefore possible that 
if MCF7 cells were plated on a different substrate then a role for PKNl in cell motility 
would become evident.
Results from the MDAMB-468 cell line are intriguing since the substrate specific effects 
on migration vary according to the motility assay used. In the scratch wound assay PKN 
isoforms have the greatest effect on migration on fibronectin since depletion of the 
isoforms by siRNA results in a 40 % reduction in migration. However in the Boyden 
chamber migration assay when the underside of the membrane is coated in fibronectin 
the PKN isoforms play no role in migration of the cells to the coated surface of the 
membrane. At first glance these contrasting results seem unexpected but given that the
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two assays are measuring fundamentally different types of cell motility it is perhaps not 
surprising that there are some differences in requirements for the PKNs. In the Boyden 
chamber assay cells are chemotaxing and migrating as individual cells towards a serum 
and substrate gradient. In contrast, in the scratch wound assay, as well as cell-matrix 
contacts the cells also have substantial cell-cell contacts that must be regulated to co­
ordinate migration of groups of cells. Despite the lack of involvement of the PKNs in 
migration towards fibronectin they do play a role in migration of the MDAMB-468 cells 
towards both laminin and collagen where respectively a 40% and 25% decrease in 
migration is seen upon knockdown of the PKNs.
Isoform specific requirements also differed between the two migration assays used.
In the Transwell assay the isoforms were found to have redundant function in that in 
order for a decrease in migration to be seen all three isoforms had to be targeted by 
siRNA. Knockdown of any single isoform or combination of two isoforms did not result 
in a decrease in migration. However in the scratch wound assay when cells are 
migrating on fibronectin knockdown of PKNl or PKN2 was found to have a negative 
effect on migration whereas PKN3 knockdown decreased the effect of PKNl or PKN2 
knockdown. Since knockdown of PKN3 did not affect the level of depletion of PKN 1 or 
PKN2 that was achieved this suggests that whilst PKNl and PKN2 regulate migration in 
a positive way, PKN3 has a role to play in inhibiting cell migration in this cell type. This 
points to differing roles for the PKN isoforms in the complex network of signalling 
pathways that contribute to breast cancer cell migration. The Boyden chamber invasion 
assay mimics more closely the in vivo mode of motility associated with cancer 
metastasis by looking at the ability of cells to invade into a layer of extracellular matrix 
proteins. Using this assay it was demonstrated that PKNs contribute to the invasion of 
MDAMB-468 cells. However it is not yet known which of the specific isoforms are 
important for invasion of these cells. In addition to the results presented here, work 
carried out by Dr Sylvie Lachmann in the lab has shown that PKN2 is the predominant 
isoform regulating migration of 5637 bladder cancer cells. This is true for both types of 
migration assay and additionally in these cells, substrate has less of an effect on the 
PKN contribution to migration than in the MDAMB-468 breast cancer cells. In
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summary the nature of PKN involvement in regulating cell motility appears to be 
complex and the substrate and isoform specific effects observed are dependent on cell 
type.
Work with inhibitors of the PKNs has suggested that the catalytic activity of the PKNs 
is required for cell migration. In both the MDAMB-468 and the bladder cancer cells 
treatment with three different compounds known to inhibit PKNl,  PKN2 and PKN3 
significantly inhibits migration. Care needs to be taken when interpreting results 
obtained with chemical inhibitors since due to the highly related nature of kinases a 
single compound very rarely inhibits a single kinase. However this data with structurally 
different compounds when taken alongside the siRNA data strongly suggests that the 
PKNs play a role in cancer cell migration.
In an attempt to uncover why the PKNs affect cell migration the effect of PKN depletion 
on the cytoskeleton was investigated. A spreading assay was chosen since the ability o f 
cells to adhere and spread is a component of the Boyden chamber migration assay that 
demonstrated a PKN involvement in cell migration. Whilst overexpression of PKN 1 was 
shown in the last chapter to affect the organisation of the actin cytoskeleton in response 
to hyperosmolarity no evidence of an effect on the cytoskeleton or overt changes in cell 
morphology upon PKN depletion were observed here. However the effect of depletion 
of the PKNs on the cytoskeleton was only examined in spreading cells, it is possible that 
if one were to examine cytoskeletal rearrangements at the leading edge then a defect in 
the actin or microtubule networks would be evident. Closer examination of the effects of 
PKN depletion on the cytoskeleton, particularly real time analysis of cytoskeleton 
rearrangements in migrating cells would be of great interest but were unfortunately 
beyond the time constraints of this work.
Dissecting the precise motility signalling pathways that the different PKN isoforms lie 
on will be a demanding task but will undoubtedly lead to an increased understanding of 
the substrate and motility specific requirements demonstrated in this chapter. Following 
on from this work the next chapter will explore a reported target o f PKN and whether 
this interaction contributes to the PKN functions presented so fa
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Chapter 5 
PKN and PLD
5 Introduction
Phospholipid metabolising enzymes such as PI3-kinase, phospholipase C and 
phospholipase D (PLD) generate lipid second messengers that play a crucial role in 
signal transduction (see 1.5.2). PLD activity produces PtdOH that can be further 
metabolised to produce DAG and lysophosphatidic acid (LPA), both of which also have 
second messenger functions. There are two mammalian PLD genes (PLDl and PLD2) 
that both have splice variants, the precise roles of these splice variants is unclear. The 
isoforms are widely expressed but appear to have different subcellular distributions and 
regulation (for review see (Foster and Xu, 2003)).
Although PLD isoforms have been associated with many aspects of cell physiology of 
particular interest to this thesis are reports of PLD involvement in cell migration. For 
example in MDAMB-231 cells PLD was shown to stimulate cell migration and invasion 
in response to serum withdrawal (Zheng et al., 2006). This contribution to cell migration 
is possibly linked to the regulation of PLD by Rho and Arf GTPases (Powner and 
Wakelam, 2002) and their effects on the actin cytoskeleton.
PKNl and PKN3 have been previously shown to interact with PLDl and to stimulate 
PLDl activity in vitro (Oishi et al., 2001). Additionally PKNl was shown to mediate the 
aiA-adrenergic receptor stimulated activation of PLDl (Parmentier et al., 2002). The 
results from inhibitor and siRNA studies in the previous chapter have indicated a 
requirement for protein kinase N (PKN) isoforms in the migration and invasion of 
MDAMB-468 cells.
This chapter therefore investigates if the PKNs contribute to the migration of MDAMB- 
468 cells through activation of PLD.
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5.1 PKNl and PLD colocalise.
PKN 1 and PLDl have been reported to interact (Oishi et ah, 2001) and it was decided to 
examine the cellular distribution of PKN 1 and PLD isoforms to investigate if they 
localise to the same areas of the cell. DsRed-PKN 1 was co-transfected with either GFP- 
PLDla, GFP-PLDlb or GFP-PLD2 in MDAMB-468 cells. Previously it had been 
observed that DsRed-PKN 1 translocated to punctate structures in response to 
hyperosmotic stress (see Chapter 3). Transfected cells were therefore either untreated or 
subjected to 30 minutes of hyperosmolarity prior to fixing the cells and examining slides 
by confocal microscopy. A degree of colocalisation was observed in most cells 
expressing both DsRedPKN 1 and a GFP tagged PLD isoform both under basal 
conditions and after hyperosmotic stress. Under basal conditions both PKN 1 and all the 
PLD isoforms had a diffuse cytoplasmic and nuclear distribution with some increased 
intensity of signal at points of membrane protrusion. An example of this type of 
localisation is seen with GFP-PLDla and GFP-PLD2 in the top two panels o f Figure 
5:1. In response to hyperosmotic stress GFP-PLD isoforms were seen in some cases to 
translocate to punctate structures in a similar manner to PKN 1. Like PKN 1 expressing 
cells the translocation to punctate structures did not occur in 100% of cells and appeared 
to occur more frequently in GFP-PLD 1 expressing cells. When GFP-PLD isoforms were 
expressed with DsRed-PKN 1 it was seen that the two proteins did colocalise in these 
punctate structures as demonstrated by GFP-PLDla in the bottom two panels of Figure 
5:1. These observations suggest that PLD isoforms and PKNl are closely associated 
under some circumstances suggesting that they may participate in the same signalling 
pathway in response to certain stimuli. Since results from chapter 4 suggested that PKN 
isoforms may play a functional role in motility of MDAMB-468 cells the localisation of 
the proteins at points of membrane protrusion could be relevant to a role in controlling 
cell motility. Following on from these colocalisation observations the importance of 
PLD activity for migration of MDAMB-468 cells was investigated.
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Figure 5:1 DsRed-PKN 1 and GFP-PLD isoforms have overlapping localisation.
MDAMB-468 cells were transiently co-transfected with DsRed-PKN 1 and either GFP- 
PLDla, GFP-PLDlb or GFP-PLD2 and either untreated (basal) or subjected to 30 
minutes of hyperosmolarity by treatment with 0.4M sucrose (hyperosmotic stress). All 
images are a representative single 1 .OpM ‘Z’ section, the scale bar is equivalent to 
lOpM.
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5.2 PLD mediated PtdOH production contributes 
to MDAMB-468 cell migration.
When cells are incubated in the presence of a primary alcohol such as butanol or ethanol 
these are used in preference to water in the hydrolysis reaction of PtdCho catalysed by 
the PLD enzyme. This results in the generation of an inert phosphatidylalcohol instead 
of phosphatidic acid. This phenomenon can be utilised in the “alcohol trap” assay to 
assess the contribution PLD mediated PtdOH production has on cell behaviour. To 
investigate if PLD activity is involved in the migration of MDAMB-468 cells, cells were 
pre-incubated with either 1% ethanol or 0.1% butanol for 1 hour prior to the initiation of 
a scratch wound assay that was also performed in the presence of the primary alcohols. 
As in the previous chapter the speed at which control cells and treated cells migrated 
into the wound were compared (Figure 5:2). Both EtOH and BtOH decreased the speed 
at which cells migrated into the wound in the otherwise confluent monolayer of cells. 
The presence of 1% EtOH or 0.1% BtOH resulted in a 40% and 30% decrease in speed 
of migration respectively. In this case the control cells were not treated with any alcohol 
so the experiment was repeated using Bt-2-OH as a control for BtOH. Additionally the 
effect of combining PKN isoform depletion with BtOH treatment was investigated. As 
can be seen in Figure 5:3 consistent with findings in the previous chapter, depletion of 
PKN isoforms results in a reduction in the speed of MDMB-468 cell migration 
compared to the LUC control (in this experiment 65%). The presence of BtOH results in 
a 53% decrease in migration speed compared to LUC transfected cells that were treated 
with Bt-2-OH. However there is no additive effect of both PKN isoform depletion and 
treatment with BtOH since the decrease in speed of migration is similar for PKN 
depleted cells whether they were treated with Bt-2-OH or BtOH. These results suggest 
that PLD generated PtdOH plays a role in controlling migration o f this transformed 
breast cell line. Since BtOH treatment did not increase the negative effect on migration 
observed by PKN depletion alone it is possible that PKN and PLD are operating in the 
same signalling pathway to control migration. However it is also possible that the PKNs 
and PLD are operating in parallel pathways and no additive effect is seen due to 
inadequate sensitivity o f the assay or one pathway overriding the effects of the other.
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Figure 5:2 Effect of EtOH and BtOH on MDAMB-468 migration.
Confluent layers of MDAMB-468 cells were pre-treated for 1 hr as indicated prior to 
scratch wound assays being performed. The speed of migration is shown relative to an 
untreated control; n=l performed in triplicate, error bars display the standard error.
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Effect of BTOH and PKN knockdown on MDAMB-468 migration
1 .4
1.2
1
0.8
0.6
0.4
0.2
LUC SiRNA PKN sIRNA 
BT-2-0H
LUC SiRNA PKN siRNA 
BTOH
Figure 5:3 Comparing the effects of inhibition of PtdOH production and 
knockdown of PKN isoforms on migration.
MDAMB-468 cells were transfected with siRNA oligos, either a LUC control oligo or 3 
separate oligos each targeting a PKN isoform (PKN siRNA). 72 hrs post-transfection 
cells were incubated in either 0.1% Bt-2-OH or 0.1% BtOH for 1 hr prior to a scratch 
wound assay being performed in the presence of the same concentrations of primary or 
secondary alcohols. The speed of migration is expressed relative to the LUC transfected/ 
BT-2-0H treated control cells; n=l performed in triplicate; error bars display the 
standard error.
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5.3 PtdOH levels increase in migrating MDAMB- 
468 cells.
To investigate if the PKNs are involved in the control of PLD activity in MDAMB-468 
cells the effect of PKN depletion on PtdOH levels was examined. Liquid 
chromatography tandem mass spectrometry (LC-MS/MS) was used to measure PtdOH 
levels in migrating and non-migrating cells and look at the effect of knockdown of the 
PKNs on PtdOH production. To increase the percentage of cells that were at a wound 
edge and hence stimulated to migrate, multiple wounds were made in confluent dishes 
of MDAMB-468 cells. To adjust for variations in cell numbers between different 
samples the PtdOH levels were calculated relative to the amount of PI in each sample. 
Figure 5:4 shows the average PtdOH levels from three such experiments with the level 
of PtdOH expressed relative to the non-migrating, LUC control sample. The amount of 
PtdOH increased almost 40% in cells that were migrating into multiple scratch wounds 
compared to non-migrating cells if PKN isoforms had not been depleted (LUC control). 
Depleting the levels of PKN isoforms did not have an effect on the amount o f PtdOH 
extracted from a confluent monolayer of cells. However depletion of the PKNs 
prevented the increase of PtdOH levels seen when control cells were stimulated to 
migrate into wounds in the monolayer. This suggests that the PKN isoforms do not 
affect the basal activity of PLD enzymes but that one or more of the PKN isoforms 
stimulates PLD activity in migrating cells.
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Figure 5:4 PtdOH levels in migrating MDAMB-468 cells and effects of PKN 
depletion.
Lipids were extracted from cell samples and analysed by LC-MS/MS. The results shown 
are the average PtdOH levels relative to PI levels and are expressed relative to the non­
migrating, LUC control cells. Bonferroni corrected Z tests were performed; n=3; n.s. 
represents no significant change in PtdOH levels relative to the control; * represents 
p<0.05.
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5.4 PLD1 expression overcomes effect of PKN 
isoform depietion on migration.
To investigate if over-expression of PLD iso forms can stimulate migration, MDAMB- 
468 stable polyclonal cell lines expressing either GFP, GFP-PLDla, GFP-PLDlb or 
GFP-PLD2 were produced. The effect of depleting the PKN isoforms on their ability to 
migrate in a scratch wound assay was then examined (Figure 5:5). The expression of the 
PLD isoforms did not increase the basal speed of migration, in fact the PLD expressing 
cells migrated slower than the GFP control cells. However whilst the depletion of PKN 
isoforms in the GFP cells resulted in a 20% decrease in speed of migration no effect of 
PKN depletion on migration was observed in the GFP-PLDla or GFP-PLDlb cell lines. 
The GFP-PLD2 cell line displayed a 10% decrease in migration upon knockdown of the 
PKNs. These results suggest that expression of PLD isoforms and in particular PLDl 
can rescue the effects of PKN depletion on migration of MDAMB-468 cells. However 
these results are only preliminary data and this needs to be repeated so that statistical 
analysis can be performed and the depletion of the PKN isoforms confirmed by western 
blot before any firm conclusions can be made. Additionally the consequence of 
expressing a plasmid stably appears to affect the effect of PKN knockdown on migration 
since only a 20% decrease in speed of migration is seen upon PKN depletion in the GFP 
control cell line, this could be due to a less efficient knockdown being achieved. To try 
and circumvent this problem a stable inducible system of knockdown using plasmids 
encoding shRNA could be utilised.
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Effect of PKN depletion on migration o f GFP-PLD expressing MDAMB-468
cell lines
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Figure 5:5 Effect of PLD expression on migration of MDAMB-468 ceils.
MDAMB-468 stable polyclonal cell lines expressing GFP, GFP-PLDla, GFP-PLDlb or 
GFP-PLD2 were produced. These cell lines were transfected with siRNA oligos (either 
LUC control or a combination of three siRNA oligos targeted against the three PKN 
isoforms) and a scratch wound assay was performed. The graph shows the speed at 
which these cell lines closed the wound relative to the GFP cell line transfected with the 
control siRNA; n=l performed in triplicate; error bars display the standard error.
126
5.5 Discussion
This chapter adopted a candidate approach to attempt to define the molecular basis 
behind previous observations that the PKN isoforms may contribute to the motility of 
MDAMB-468 cells. PKNl and PKN3 have been previously found to interact with PLDl 
both in vivo and in vitro (Oishi et al., 2001) and since PLD isoforms have been 
implicated in transformed cell motility (Zheng et al., 2006) it was considered possible 
that PKN and PLD may cooperate in controlling migration.
Co-transfection of RFP-PKN1 and GFP-PLD isoforms suggested that there is a level of 
interaction between PKNl and PLD isoforms. PLD la  and PLD lb were seen to 
colocalise with PKN 1 in some cells in response to hyperosmotic stress. Additionally 
some colocalisation between PKN 1 and PLD isoforms was observed in membrane 
protrusions in MDAMB-468 cells under basal conditions. Difficulties of co-transfecting 
two constructs meant that these localisation studies were not as extensive as they could 
have been. It would be most interesting to examine the localisation of endogenous 
PKN 1 and PLD isoforms unfortunately though the antibodies available are of 
insufficient quality for use in immunoflouresence.
Directly measuring the levels of PtdOH in cells using LC-MS/MS demonstrated that 
PtdOH levels increase in actively migrating MDAMB-468 cells. This finding is 
consistent with the observation that treating cells with primary alcohols decreased the 
speed at which they are able to migrate. Although primary alcohols are likely to affect 
cellular activities other than just PLD catalysed hydrolysis o f PtdCho their effect on 
migration when considered with the LC-MS/MS results strongly imply that PtdOH 
production contributes to the ability of MDAMB-468 cells to migrate. These results 
however do not inform us whether PtdOH acts directly to promote migration or whether 
it is an intermediate signalling molecule and derivatives such as DAG are the direct 
effectors regulating the activity and localisation of proteins such as the cPKCs. 
Interestingly PKN depletion inhibited PtdOH production in migrating cells to the levels 
seen when cells were not actively migrating. This suggests that the increase in PtdOH 
production seen in migrating cells is a consequence of the presence of PKN isoforms. 
Since PKN I and 3 have been shown to stimulate PLD activity it is tempting to
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hypothesise that PKN activity is required for the migration stimulated increase in PtdOH 
production but this has not been tested here. It therefore remains possible that PKN 
isoforms play a scaffolding role in regulation of PLD activity.
To summarise, it appears that PLD function is required for MDAMB-468 cell migration 
and that PKN isoforms operate upstream of PLD in the generation of second messenger 
PtdOH. These results suggest that PLD lies downstream of PKN in a signalling pathway 
that contributes to the control of MDAMB-468 cell migration.
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Chapter 6 
Discussion
6 Overview
The work presented in this thesis strengthens the link between the PKNs and the 
cytoskeleton. The PKNs have previously been described to be activated by Rho 
GTPases (Amano et al., 1996b), (Flynn et al., 1998), (Watanabe et al., 1996) that are 
major regulators of the cytoskeleton and to interact with numerous cytoskeletal 
components such as the actin binding protein a-actinin (Mukai et al., 1997). The work 
presented here looked at the PKNs in two contexts o f dynamic cytoskeleton 
rearrangements, hyperosmotic shock and cell motility. In the first instance 
overexpression of GFP-PKN1 was seen to disrupt the actin cytoskeleton in response to 
sucrose induced hyperosmolarity and stabilise actin filaments in response to 
hyperosmolarity caused by urea, highlighting the complex nature of the signalling 
pathways that regulate the cytoskeleton. The translocation of PKN 1 to punctate 
structures in response to hyperosmolarity was found to be specific for sucrose over urea 
induced hyperosmotic stress suggesting that PKN 1 is responding to mechanical stress 
rather than hyperosmolarity per se. The translocation observed here for PKN 1 was 
shown to be mediated through a novel 49 amino acid region located within the PKN 1 
kinase domain.
In searching for a role for the PKNs in cell motility it was found that the contribution of 
the PKNs is cell type dependent and that the relative contribution of the three isoforms 
varies depending on the specific nature of cell motility being assessed. Attempts to 
define a molecular basis for the PKN role in cell migration pointed towards a role for the 
PKNs in activation of PLD isoforms in migrating cells and interestingly PLD isoforms 
have been implicated previously in control of the cytoskeleton (Komati et al., 2005). 
Further work is needed to fully understand the exact nature of PKN effects on cell 
motility and whether they contribute to regulation o f the cytoskeleton in this context or 
whether they contribute to regulation of cell motility in another manner.
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6.1 PKNl and the cytoskeleton
In searching to further our understanding of previous characterisation of PKN 1 as a 
stress responsive kinase it was found that over-expression o f GFP-PKN 1 altered the 
rearrangements of the actin cytoskeleton seen in response to hyperosmolarity. Given the 
PKNs control by Rho GTPases it is perhaps not surprising that overexpression would 
affect the cytoskeleton since the presence of higher concentrations of specific effectors 
of the Rho GTPases is likely to disrupt the fine balance that exists normally to control 
the cytoskeleton.
Depletion of PKN isoforms by siRNA resulted in a decrease in the ability of MDAMB- 
468 cells to both migrate and invade. It would be interesting to examine further the 
dynamics of cytoskeletal regulation in these cells. Recent advances in optical imaging 
means that the visualisation of metastasising cells is now a possibility (Sahai, 2007). 
Combining this with the expression of fluorescent tagged proteins would allow effects 
of PKN depletion on the cytoskeleton of invading cells to be examined. Although no 
overt affect of PKN depletion on the actin or microtubule networks was observed in 
spreading cells it is possible that an examination o f the cytoskeleton in migrating or 
invading cells would highlight defects. Live imaging using tagged actin or tubulin 
would be a powerful way of examining cytoskeleton dynamics at the leading edge. 
Additionally it would be interesting to probe the link between PKNs and cell surface 
receptors that mediate cell-cell and cell-matrix adhesion and associated proteins that 
provide a link between these receptors and the cytoskeleton. Sites of cell-matrix 
adhesion such as focal adhesions have been suggested to allow integrins to act as 
mechanosensors (for review see (Katsumi et al., 2004)) and the PKNl translocation in 
response to hyperosmotic stress was suggested by results presented in chapter 3 to be 
due to mechanical stress caused by membrane impermeant solutes such as sucrose. 
Perhaps this translocation of PKN 1 and associated signalling events is activated 
downstream of particular integrin activation. This could be investigated through the use 
of integrin blocking antibodies (Crowe and Ohannessian, 2004) to examine effects of 
inhibiting specific integrin dimer activation on PKN I translocation. Supporting the idea 
that the PKNs are activated downstream of specific cell surface receptors is the finding
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that the PKN contribution to migration of MDAMB-468 cells is substrate dependent. 
The strongest effect of PKN depletion on migration was seen when cells were migrating 
on fibronectin perhaps implicating PKN activation downstream of fibronectin binding 
integrins such as a4/5pl or aV/IIbp3. Differential activation o f integrins has been 
shown previously to regulate cell motility by selectively modulating the activities of 
Rho GTPases and their effectors. For example in squamous epithelial cells collagen 
a 2 p l integrin binding activates Rho A and slows migration whereas laminin-5-a3pi 
integrin binding activates Cdc42, Rac and their downstream effector PAKl to stimulate 
migration (Zhou and Kramer, 2005).
6.2 PKN in motility
Work carried out in our lab with transformed breast and bladder cell have suggested that 
the PKNs can contribute to cell motility. Data from siRNA studies presented in chapter 
4 suggest that the isoforms display redundancy in some contexts such as the Transwell 
migration assay and that the involvement of the PKNs is cell type dependent. At least 
for migration in a scratch wound assay the catalytic activity o f PKN appears to be 
important although this does not rule out the PKNs also having scaffolding roles to play 
in the signalling pathways that control cell motility. Care does need to be taken when 
interpreting these results from siRNA and inhibitor studies since both oligos (Jackson 
and Linsley, 2004) and kinase inhibitors are known to have off-target effects. The 
possibility of off-target effects were minimised in these studies by using low 
concentrations of oligo (5nm) and ensuring that the sequences were specific for the 
intended target by using the NCBI blast resource. However to further strengthen these 
findings it will be necessary to use multiple siRNA oligos and ideally to also perform 
rescue experiments with siRNA resistant PKN isoforms.
Encouragingly though the PKN isoforms have been previously reported to be involved 
in the migration and metastasis of astrocytes and PC3 cells respectively (Bourguignon et 
al., 2007), (Leenders et al., 2004). Additionally phenotypes o f the PKN' ' Drosophila 
and PKNl '^ ' mice further suggest a role for the the PKNs in migration. Drosophila
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PKN  ^ are embryonic lethal due to defects in dorsal closure (Lu and Settleman, 1999). 
Dorsal closure involves migration of the lateral epidermal flanks and dynamic changes 
in cell shape to close a hole in the dorsal epidermis occupied by an epithelium called the 
amnioserosa. The dorsal closure process has been likened to migration of epithelial cells 
in other organisms and in a similar manner Rho GTPases have been shown to play an 
important role (Wood et al., 2002). PKNT^ mice do not display an overt phenotype, 
perhaps due to the presence of PKN2 and PKN3 that in some contexts (for example 
migration through a Transwell) may have redundant function with PKN 1. Interestingly 
though these PKN T 'm ice do have a decrease in the number of circulating neutrophils in 
response to an inflammatory stimulus. This has been hypothesised to be due to defects 
in the migration of neutrophils out of the bone marrow and into the circulation (Dr 
Casamassima, personal communication).
6.3 PKN specific domains
The PKN isoforms like many proteins have distinct domains that allow their activity and 
localisation to be precisely regulated. These domains can therefore be expected to 
contribute to the functioning of the PKN isoforms in distinct signalling pathways. The 
work presented in chapter 3 demonstrated that a novel 49 amino acid region located 
within the kinase domain of PKN 1 is required for the translocation of PKN 1 in response 
to hyperosmotic stress. The highly related kinase domain of PKC(^ however does not 
respond in a similar fashion to hyperosmolarity. To confirm the importance of this 
domain for control of PKN 1 localisation it would be elegant to be able to alter the 
behaviour of the PKC^ kinase domain to resemble that of PKN 1 by mutation of the 
relevant amino acids. PKN2 has been found previously to also translocate to punctate 
structures in response to hyperosmotic stress and as you would predict these 49 amino 
acids are highly conserved between PKNl and PKN2. However it is clear that despite 
some similarities in function between the PKN isoforms they are also capable of having 
distinct effects. In the context of cell motility it has been found in PC3 cells that PKN3 
is required for invasive growth but PKNl and PKN2 are not (Leenders et al., 2004).
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Work presented here suggests that the migration of a sheet of MDAMB-468 cells is 
predominantly controlled by PKNl and PKN2. In contrast in a Transwell migration 
assay where cells are migrating as single cells the isoforms appeared to have entirely 
redundant functions. It is not clear from these experiments whether in these contexts the 
PKNs are operating within the same pathway or in parallel to each other. To gain a 
handle on this it might be informative to examine which Rho GTPases the PKN 
isoforms are operating downstream of in response to motility stimuli since the Rho 
family GTPases have distinct roles in cell motility (see 1.8.2). The requirement for PKN 
in the dorsal closure of Drosophila embryos was recently shown to be dependent on Rho 
but not Rac binding (Betson and Settleman, 2007). Additional domains of the PKN 
isoforms such as the proline rich domains of PKN2 and PKN3 are also likely to play a 
role in controlling the action of the PKNs. The proline rich regions in particular have 
been shown to allow binding of SH3 domain containing proteins that may aid the 
formation of isoform specific signalling complexes (Quilliam et al., 1996) (Braverman 
and Quilliam, 1999) (Shibata et al., 2001) and contribute to isoform specific functions.
6.4 Signalling downstream of PKN
Signalling pathways downstream of the PKNs remain broadly undefined although 
several links have been made to the MAPK cascades and in particular the p38 pathway 
(Takahashi et al., 2003). Interestingly the recruitment of PKNl to a distinct 
compartment in response to hyperosmotic stress has been linked to signalling to the INK 
cascade. Work by Dr Cassimassima in our lab has highlighted that the phosphorylation 
of both MKK4 and JNK in response to hyperosmolarity is reduced in PKN 1 ' ' MEFs. 
Although this phenotype is unstable in culture, perhaps due to compensation by PKN2 
and PKN3, it has been found ex vivo that the same deficiency in JNK phosphorylation is 
seen in the heart in response to ischemia/reperfiision. Further work identified the Rac 
dependent assembly of a complex containing JNK, JIP (JNK interacting protein) and 
MKK4 (Dr Casimassima, personal communication). Interestingly JNK has been 
suggested many times to be important in cell motility (reviewed in (Xia and Karin,
133
2004)) however no effect of either PKN depletion or inhibition on the MAPK cascades 
has been observed in migrating, transformed bladder cells (Dr Lachmann, personal 
communication). However defects in MAPK signalling could be localised to events at 
specific cellular locations such as recruitment of phosphorylated JNK to the leading 
edge of cells. Hence microscopy studies might be more informative than examining the 
phosphorylation state of components o f the pathways in the whole cell population. 
Results from chapter 5 suggest that one of the important downstream targets of PKN in 
cell migration is PLD. The results presented suggest that PLD activity is required for the 
migration of MDAMB-468 cells although this is contradictory to findings in HeLa cells 
that demonstrated that PLDl regulated cell migration in a lipase activity independent 
manner (Kim et al., 2006). In our system inhibition of PtdOH production by primary 
alcohols decreased cell migration and most interestingly PtdOH levels were seen to 
increase in migrating cells in a PKN dependent manner. Perhaps the link between PKN 
and PLD is of relevance to the phenotype observed in PKN ''' mice of decreased 
circulating neutrophils since PLD has been suggested to regulate the migration of 
neutrophils (Powner et al., 2007). Colocalisation of PKNl and PLD was observed 
particularly at the points of membrane protrusion and in response to hyperosmotic 
stress. It would be most interesting to examine the localisation o f endogenous proteins.
It would also be interesting to perform immunoprécipitations to examine if the 
previously reported interaction between PKN I and PLD increases in response to 
migratory stimuli. Initial experiments suggested that PKN knockdown can be rescued by 
expression of PLD isoforms particularly PLD 1 although these can only be considered as 
preliminary results and further experiments are needed to confirm this observation. It 
would also be interesting to examine if the migration of the GFP-PLD expressing cell 
lines is compromised by inhibition of the PKNs. Taken together though these results 
implicate PKN isoforms in signalling upstream of PLD to regulate migration of these 
transformed breast cells. It would be interesting to examine which of the PKN isoforms 
contributes to this signalling pathway. One hypothesis is that it would be PKN 1 and/or 
PKN3 since these are the isoforms previously demonstrated to interact with PLDl 
(Oishi et al., 2001).
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6.5 PKN and the cell cycle
Interestingly knockdown of the PKNs although not formally investigated here showed 
no signs of inhibiting the cell cycle since 72 hours post-transfection there were similar 
numbers of LUC control or PKN siRNA treated cells. This is in contrast to HeLa S3 
cells where knockdown of PKN2 was seen to slow the cell cycle due to a block at the 
G2M transition (Schmidt et al., 2007), In vascular smooth muscle cells however the 
phosphorylation of Cdc25c by PKNl results in a delay to mitosis (Su et al., 2007). It 
therefore appears that the PKNs have a cell type specific role in control of the cell 
cycle. Interestingly it has been suggested that cell cycle delay is one of the consequences 
of exposure to hyperosmolarity (Dmitrieva et al., 2001). This raises the intriguing 
possibility that PKN 1 translocation to punctate structures under hyperosmotic conditions 
may be linked to a signalling requirement for delay of the cell cycle. Perhaps by 
sequestering PKNl in a discrete compartment/complex the cell cycle is delayed 
allowing the cell time to adapt to the stress conditions. Alternatively the PKNs have 
been linked to apoptosis (Takahashi et al., 1998) (Sumioka et al., 2000) and this is also a 
consequence of prolonged hyperosmotic stress (Reinehr and Haussinger, 2006). The 
recruitment of PKNl to a distinct compartment along with components of the JNK 
cascade supports the idea that PKN 1 may be involved in apoptotic signalling in response 
to hyperosmolarity since JNK has been shown to have both pro and anti apoptotic roles 
(Lin, 2003).
6.6 Future directions
The relevance of the PKN 1 translocation to punctate structures in response to 
hyperosmolarity is intriguing and as yet not understood. It would be most interesting to 
utilise siRNA to look at the effects of PKNl depletion on gene expression, using 
microarrays, in response to hyperosmolarity. In a similar way 2-D protein gels could be 
used to investigate protein modifications mediated by PKN I in response to 
hyperosmolarity. These techniques could be expected to further our understanding of the
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role of PKN 1 in the hyperosmotic stress response and may also provide possible targets 
of PKN 1 signalling in other contexts too such as cell motility.
Pathologically cell motility is of exceptional importance since the ability of neoplastic 
cells to migrate out of the primary tumour mass and colonise other sites in the body is 
frequently the cause of patient mortality (Spom, 1996). Despite evidence presented here 
suggesting that the PKNs contribute to the ability of transformed breast cells to migrate 
and invade in vitro this has yet to be tested in vivo. PKN3 has been shown previously to 
be required for the metastasis of PC3 cells transplanted into mice (Leenders et al.,
2004). It would be interesting to test the contribution of the PKNs in metastasis of 
transformed breast and bladder cells.
The link between PKNs and signalling in response to steroid hormones would be an 
interesting area of investigation particularly as PKN 1 has already been described to 
activate the androgen receptor in PC3 cells. Aberrant hormone signalling is often 
responsible for the proliferation of neoplastic cells, classically those cells of hormone 
responsive tissues such as the breast and prostate. Interestingly though the proliferation 
of transformed bladder cells has recently been linked to androgens and the androgen 
receptor (Miyamoto et al., 2007) perhaps explaining why bladder cancer is almost four 
times as common in men than women (Jemal et al., 2006).
To conclude it is clear that the PKNs have diverse roles to play in signal trasnduction. 
Elucidation of their targets and interaction partners will help further our understanding 
of their role in controlling physiological responses to specific stimuli. This thesis has 
primarily focused on their potential role in control o f the cytoskeleton and has revealed 
isoform and cell type specific roles for the PKNs in control of cell motility. The 
contribution of PKN signalling to the migration of MDAMB-468 cells is suggested to be 
mediated at least in part through activation of PLD although the downstream targets of 
PLD relevant to migration in this system are as yet unidentified. Figure 6:1 proposes a 
model for the PKN/PLD contribution to cell migration.
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Figure 6:1 Model of PKN/PLD involvement in cell migration.
Activation o f Rho family GTPases downstream o f integrin engagement with ECM 
components is hypothesised to result in recruitment and activation o f PKNs at the 
plasma membrane along with PLD. The resulting PtdOH produced affects the activation 
and localisation o f multiple downstream effectors to bring about changes in the 
cytoskeleton and gene expression to regulate migration.
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